var title_f22_37_23120="Increasing plasma cholesterol and coronary risk";
var content_f22_37_23120=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F60146%7ECARD%2F50334%7ECARD%2F78556&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F60146%7ECARD%2F50334%7ECARD%2F78556&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Association of increasing plasma cholesterol and coronary risk",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 238px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Relation between plasma cholesterol concentration and six-year coronary heart disease risk in 361,662 men (ages 35 to 57) screened during the MRFIT study. There is a continuous, positive, graded correlation between the plasma cholesterol concentration and coronary risk. To convert plasma cholesterol to mmol/L, divide by 38.5.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Stamler J, Wentworth D, Neaton JD. JAMA 1986; 256:2823.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Plasma cholesterol and cardiovascular mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 256px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Relation between the baseline plasma cholesterol concentration and ten-year cardiovascular death rate in patients without and with manifestations of coronary heart disease (CHD) in the Lipid Research Council study. Cumulative death rates were increased at higher plasma cholesterol levels in both groups, but the effect was more pronounced in patients with preexisting CHD.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Pekannen J, Linn S, Heiss G, et al. N Engl J Med 1990; 322:1700.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Death from coronary heart disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 322px; height: 422px; background-image: url(data:image/gif;base64,R0lGODlhQgGmAcQAAP///wB/AICAgH0A//8AAAAAAAA/AAAA/z4Af38AADMzM4iIiBEREczMzFVVVXd3d6qqqgAAf+7u7iIiIkRERJmZmd3d3WZmZsDAwEBAQLu7ux8APz8AAAAAPwAfAAAAACH5BAAAAAAALAAAAABCAaYBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJFrGAKVlpeYmZqbnJ2en6ChoqOkpaanoIICGaitrq+wsbKzsAWqApKLtoGVuYq7gL2+iMB/wiaUpxjDacV+xyUCHRHU1dbX1h24zGfOfdAkAhEH5OXm5+YR29xl3nzgI+Lo8+jq7Gbue/Ai8vT+B/bukcmnZx+Afv/mBRQohmAegwgTnlvIEIxDPBDHSay3zseCAgt2OCjQIIiCCRac/zRgoODIxTsZN3JE0aBAgQcAIBRwEOPjAp08Tygg2WJkSRILGNi8AOAjTgBDIdS0WYACBBMPClwFoLSlhAIMViS1eTUr1ZYWKNikIGGET7cgjby0E1Nmuo4kppIE2jOuDqNIq4pwAMGpiKg10Q7VUILlCKUgv4ZNkTXkiKxPDxfQUGEngK82LYuYMEHuLRQR7VLMW2BCAQV8GwytmnKEhJFkfdbkORR3SMAfbT7QGxfwCNe1RRiGqjWxCJ0USGjwy5XBBAY1w4KmqrW6awUlzb5uIFkEg8lNqQO4QJTI3Dp17ZJbPWI3e7U8r0uY3nLESNG6ebbYdGEZ9VFQrBXY3v9nYJUQHHdSvSaCcyN0VsFjDHSmFnomOKchCZ2V5lpJ58ElWnpbDfEeHfHJR9+EO0ng2k7OgdaWeQXcmN4CuzFHXoNGjZSiBbjZdNuCXBWQXHpPISZhTp5VWMCF5oWlVoMoWNAagxyWB4FSrpWmnHofpSjEinO0qBpe9Xmmk2f68UfCfyb2ONSPCjZwoH9xKXXkUWNGBwBhyzmp2GbSUVeiBEppxx1ZzHHmGWEAdIbgelOaSAJ7gJ552gmpyfQiAD0O6plsay15ZG4g2UlSecBRNVxXfhrnFmRMFdocdxR0al5/1Y3JoQlp2eRAW+Idm95rVG6HJQCkmcYLm/xoJB//QNTukZWZTLxVBJpyqClqtnuctKQSKwHr3qcmhLrRqBVpAW4c4r5LbrxYzAtHvRLBi+8V+r7Bb0L+/ltFwG5ANA02DF+jjcFeINyGQcmYsgzEXEjMhkEYz6HxGhx3HMfHaoQs8hskp2HyyW2kjMbKLK/h8hkwx9wMuzbLMbMZFKNycc5T7FwGRBwkYPTRSCeNNAf3Aq2E0GRAlAABVFdt9dVWJ9C000hAPYbUWIeNtdZcS+G1GGCLrTYBZJcNxdlhpL122G277QTcYMg999V1280E3l/ovXfVfUthKw/LNcEet0JIoAAD5wIAuBeCD852thQKaYRRfLFAoQqJ11Ce/ww6PTUSA23dmUJnawHqrQgy3gTjpSJM3kXlgxfeZn+aF3G450+CLnsTFKA+mLE+pnDBhR9ud2Lxw5t6ru1c4L637jDyrpVOCgylQFsVzNhSBZDxxP1QFAQXkveQGtVjA1fmCJln80t1JQUpsa5UZqamKtmGJYGAa7oSrKxAjyfEORFXBGUq11RAdbORFYii97oLKCBxnVEg9bZgvblhj1RPEhJ0AKAWHr3mRs5xygjVUgEtleZOFiiR++CEHRO4RgMU0k9nLlCT0oSOTwsoz55G5JwSVSZJgMoOCbTElON9iTRI6pBNIKeppkAucTXhn+RwFo6pWS5rmAvh9jxTmf/EGYZ7fBFSeVRXK5Ls5nMAEM+uWkKc1/AldAuY0U28RKMGFTEsR4RhkXI0AibySU9U8dUJeljF+QkHRlrcoBY6uLYPcmUCqVMSXyqTGBRKSIWT0soaSTKd0swwPzVMT3SExEhoUVEEcsJig5zCR56cZz8SMmJc7kQnP5GAAQwEzGxKEsFHWgUApawiXDKTwRJIMguUVJslITCbCVxlk3EJn03Ghyso8USNDRoKmEpySlLFz3FgiUr/7EcVnphlKPzDDTxrWamu5BKQu3QjrQg5guLdCDBTUeQI2NM6BlGFQ4kbyfS4GA8vfpFqljSC6rrwkSbSoHRJKBUJnomFaIr/LaJFmGgWxMOWGyzuCI575UYZyg+HPhSkflMRSw/i0i/CNKZB4OgVPEq3reEUCDq1Ak/H5tOf+iCoVSCa0paqNKYZ9WkzrVgpfvZUaQWjqFXNAlKpULOs5mumXu3CVqfQ1bAeDKxmlRda0/rVabE1DGOVQs+U8daczlQAHjCAXvfK177y1QNYrWsM4hoFiBggAIhNrGIXq1gDBFawLyAsFAzL2Moy1rGQPepdD2vZzgYAs5nlgWSfQFnPWha0odXBaJ1QWtNe9rGpVcFqm9Ba1zYWtkKA4wl+pwKCCrQIJzVCSiNngtkyoba2RSxqSzAVy7hGiz5wjkjntKDRmWA6/7RzgeasCwOMmsp40z2BWgBFUPBAiTtt0WgKjLsE5CZ3uazZUnCg2wPdmoC3KPBuDHpXA38eT0BRJMGb2lOZGJaGe/dV0grYqwT32ha+bVJKHveXTOzGkSohWZVWHmRN5rBygBIyEFU6fDhdHlAv4OFOSLLiAAY8QMMPakmJUEUbD4emMcFszZQg+KjMGEd14x1whqSkwOJuNrmLhXD2TmeYqLBHA4ZRCwTo5CDBRFCAbgzxgj6ySiTpMiRKQST/lCieB1DZVFspUZwkNKBnAcCQTrTOiFZgHDrZKoYKBiF9V+pWUHEWycoNY4ovYJgDOUZzmPHlc+LXEtWVxzmcY/+0qTr1ZR8ZhkjoPWKSdNS789TISHfiLpwn/aDfHlIEFhAnckgw0Swu+MiADjRNgrecGV0oylo5s1JwyOb23FJORtk1pL2Mz/WRxDC9zJGmzzwSKqkZdXIKtZsXeOphMoc7Po7iDuMYEgMT+dV9btefAa1kEAJrOVkR04XBkuEiFWabvT7Km7xHani3pMTFtrTsVvIaP2law1Ih4Ixngz8fcZeExps0CAM8ggGfaoqWGXCv+ERcPl8VNeNGcrlXoOlF6NcI6kUBg5PgYNduXAW3dERwizBcFowcCSU37cljC4OXHyHmnp05zV1gcyPgvLM637nLYR3roAtdtnfNq1//l95XwB7dBj0vwlwt9vQaRJ0IZa26TMOt9SdcfQhZ7zpQ1yr2b5G97Fu/ONqb8HUhhH3tO2h7EKY+Vbi3QO5AgMgGEMD3vvv9737fAG61jvcfQAQBA0i84hfP+MUjYPBVL7wPDt/4yjf+8XYfOtfDgXjLe34AmM880jcfj85/vvKhF73I72r60zM+9ao3Mun50XrXKx72aWiAa7JrhBgy0HeZkoHke0B527/+XmZhzAs694OOl2C8MqCQ81/wuPQ+kvkmcFZ3aBwUaj5yNOquOeuNf3wVzMiiXBiKjl5g3xhM5yl6aQD2S2AjEuiHltaRAHss8xEqiX/2B1F7xod7/wLWb8ZjQEoRFLihFBFyLGABQP1TY/VBcCnRG90xJkH0gGDRAO5WJPjzPzmiTf1GFe+2YhgGJd1zQoGhfD1kR2T0KF6BbeZmbnxhYW8WJf+ndu0igLZHgEBEJ0cUZnvCSjEySzhoKieyZo1GgiYiRPTDT8eTgYmkgjO4I7gGASukHuxRG/ZRFUeYAkNRAbExHluiUY4xWONHfreXLVrCHS0RSCRhZ7vigGFxR3qUGZ+WI+HlE/TkS3kkK6MjS/3hE4h2E9h0Ils4O7HzhSjASRKSQjbhGhZ1hjloDNkiADzoej6YHkFxQ3AoZiQ0h7WkRKGjhMkTGBlYh08oAaS4R/9Y0kkwIiY+cYWHuIKzc17uBIM5ERSqc3/RIwHFUxtawnvgpoPRkImnt4musRVZcQGfCIzpJIoNkkbwNmYUeIpNOI2r2D/z9CwieG+sYoLs5k0XdiLvd4umQoxvNiMTQCXc918TNyb+F1lpqIagB3n0t2p+UH1JEC3CV49quIkvsB1D9ge+hwTNNgPDxwPFZ48CqXoLuQMNGZD4eHQRqQMTSX4PKXoXmQMZOYAVKXQdiQN6B3gmCXiCF3urB4BSRQpUpZIjMJI38HYw+Y8AWJOidXY4CXWqwAq08JNAGZRCOZRAKZM20JJEmZRKuZRMKZQ7+ZRQWVX6RxXgAxlFFpX/kvA4SaRljIOVj1BKayEBhSY7SNmUZnmWaJmWrfCSXmAY+3dEhtGSGeCTalmXdnmXZ8kKTVABD7AAFacC2wYUY0lfNOmVMlCYJnVQpoYCjIJJ++ccUgYqIWmYLYCYorMTEEA+v+cCWOYX5HNjkkmZWDeZMwAbIvAA6uJ2pIl2ZYkJbJkCllkDF0ABD/AAFECbV0l8q1l2eMV0euV0LhCbNFBM2xQEyaCXohkNGZdkWCWcM6ABWBidEKB8P3Ccuyl2ArCct/UCzikDC1CbtZmbk3edXZedOdec5OkCxZSac5eeVWeeQIeeTACdWMgA4qmbyamc58md7gkDCrCZ7Zmf/+GgnYlldAfRn2JRm+zBnnmHoEIHn6cln0tQTPNYnZWAnAJ6EAQqa8HpoClAn1JBBNaZofywoZ8loUsgAV2pmiSqofvZoU2gE+s3mi0KoZVloN1JOlAodR5Kczb6WvwZoztKoyT6o8wZpEtQAQ2wZwFapCaKoz0qFK/xANRpnBcapallpNsJo0nqADMCoD0wok76opWJpcTyQMEDdmaaWVpaoCiaBASVPn+Jn2Man0iqBN7DIze3ppDVphxapk2gARYkGDxao0/6pkhgAQvgpWnKonUaoXeaBLNxQXOaA2KaoX56opGKBH1ZqTtwqQKaqVDqBNMJc3wqWKKKqEfAb/9USKSYeqibegSk8QAXwADqSKevSqYskKMDeYGo6XOnWlepGqtGMAGE8UC3egLadxWfqR7hEKxvNaxcqgQPkkq9CoXD1pW8Wp6wOq1KoAGdKgPOghODCQByCa1sJa2AagZhCJdkiQkYGqrduq6cCp7geZ8cBxLl2i7omlbquqtrqn3F2V28mGUtEZn8aqi6ugLbygLSGZ1V2gIWwI5U0qy52bDvOa8AqwT2eq/AqrB26q0s9ygD66ryurAqgLEq8LBYGLE+AKr5+a8Mi66lKqJXCrKQKrKrChnf87GPeqOqWqwTQKu26rO5GrL0igRfwYwManj9alYym7LBaqyZqQD/ySqRTxtWUQubwVqti8mQWetVW4safPoAKQGufmmzqxC2WTW2oam0WqEATPqyN/uzQKqzRGAd1tE9CoB+jnq0OZu0RjAWbmi0J4u0G7sEhCYBjLunOAu0xEovbFtVbpuwMDG5T1W50YC5QACzyam5z1oHniuaoBsPXRtEFHC1WPu4dyu4srqooGmyMauxM5uicdu3TTuerHukeFsELnYTv1qodsu7rmsEBEVNquuRnPtTpcsPwSqWFSABwzEEo0uZzXugTHABfisE1WuY16uydJa7TQq4N0qXnHAx4As6Lhaehju7Obd3J8l3KYm9E1q4wku+l4WMiRd66fuh0umy/w26u42lv/fovN0yP+KrAmrRHxZLtgJcoATMv1P7HUUrAw9AQNn6tvibZBG8Df2rrCCRIxeQvCCSIZ8kO3EJr8uLU6LawQasBEsrtw6QwNc1Jc7hrjhxrg+sXC5Mv3jqAGaxvXQGg/u6uTv8WT38waCDryrgHJB5gUY8vAOcjB4MrRYAASo6o+z3JA2swYd7WknctWTRt+37uU8axkwwAScBAcEru2acc2gMw3ELARZEvXW7wVP8eRKcxhZ0wULMA93rlS1MxS+sBKwDFp6KkSscU4Osx1XMBBaAtomsyEdsAHGMp+lDcovsN43seXusuFPkAADstJV8yUqgqDxbof+kLMUQTMg+nASCyo6NCsh3/MU3aspIMBQTwEOkwsQ1EMhY2cmW98nUqspuTLpn7MpKLFebbDfCjHqPfLmlrMzNjKu2nL/UjBHVXDbPfHnRDMPfyb7cW8vuC3S4fATxM8thSs5vbM7ZLMew0bJljMxw/M54OrcBzMo8bM9wOrTifMzWm8yOXMiSar8A7b0C7cnfDMv/O88BXc8D/cpKULN2vLbTHNHLzFw8q8XrbNH6jMT8jASzWqskPJPbzDXdXH4SLVy+SsOULLqf8Jpy0JqWkAEJPcwLLdLHarUOnTBKx3TACRNFw1QJwAE3Dc0EjQRe29MTQ7ssUlN8c9TenNT/SCDJ4ho/ltHFlssiTp0mUJ01Uq3SGY0UqFvSE1JSi5HBW50mXR0uX004Ye14Of26vlED1VeuOgwfbU0vbw1Rcb2GVD2y1IS7M4AbTIHD5qrCdLHX+9LXbPPX+zvXRvC7tenSKNBsRRy6eo2yXl1JkF3AK228Y2zWC9BELPTE2nrSJMnYAuPYCfDZxJwE0Cu9X9shepTVVunAm4248OHasC3ZwPXHf8vWnO3Wng3RCh3YvmPZYLvYxc3Xx+3OGN2169uXFR2v4cLaCePbyI3Tyk0E63ndqj2T2j0x3C3dyR3aRQBl0snUG1PeG3PeYBzSRxAc1CTc1pzdz93Y0T3f/9Odxmvcxmrq3Lz91P19y/Qt2LBRx/dL3AXe2dL02989BLsstwyA382924FLF/KN4P+dpAc1yb/MzvsC3yDT4dj84Utg1eJN4Bve2wee4uk91iASru4NMiZOyzFteCjOwQkOXIp54yWT4xL500CdngLQ43k846f6FccKTEKuMkSOkSaqqZOn5K2s4pLKtFH+MlPukVVuoDCQ5DHu41qOBLNZm7dp3QOu4ZDbYGGO5Fi+z2d+BMSpzjoAzDi+33MX5zxe5kvu3epNBCAKsVbq0VzN53nn51cO6FnO5Nrs4m9OcoxOfHMO0nUeLuNtA9fLkJXOkJduyT++L5teA50ukf+fLpGhfs6aLumtC3OpjpGrPuqNE85B5Lhu/uo3F+seOeuZPgSsOkW1fQN6PuSKbni8TpK+DulJ0GJAbGYVfOjYTS9fvtoyJ+eOTufMnsv8I+DDrd8PjnXJPpPLLug07uy16exdTjPVTt7X/ucR3t1IPehBEOwbuO480+6cPu6cXu7zTuOfYescnc+JHu5gx++m7u9TTe9BIJbhOfBDDJpaHcUF/+I+h/A0QObxjt7mzqf2bq0v4AAVuBlqTfGWCgoyffDHPnlhbr6akPIpq/BizafoDu1mzWobhsLvegnTzulGvnRBDesrT3xhDr8nOb8xoPEfJeEM/wNySwLe/gL/alEaiJ3XVP7ucJ5zLv/yLC9z+ruRqCHzcj3hQFDz6h4DunfvmW26no71lP6+8Su/5JmpmC7oSS/2gN300eVIIN8CU2FeM4iwJm/tQ9/2HD/vhn/4Kn332V73HZ+iAh99j8ITE6/ZV1/4qC7vC5/4/m33Y473kU32QODwfQnxupv5mH/5ne/5qr/6m//5jS/qv55bfD/sysv5ky70ir/4qL/7ec/4G+/6C3/utpru0d65JG7qGI/sms/7re/hrB+coA/aNP70l8HcNFDs3Ln8Xe/7v9/7wj/2hzn9sb05xW/z+M6w3E/0zS/+uC/jiA/7wQ/9j59RtZ/+Kbv+7x/o//EPAoA4kqVZCkawsm1gIIM804hw4qSQEL3/J1SuFoxmlNlEgluu6XxKFo/HQvK8YpfYrHDIMjC34mbK+40da+ExuWsuppHr7e5nJwTNK3h8kARosQk2WWgMsgUeorh5gSkelunxxf09LurtoVHOZfHc+eRJam4qcVqyPSicXiWeRkqarrZhTqZVyr6+jR7d0nl+4jG61PIytco6LSgsL0+oIptgLGXEDuY2VkNfivbJaV8PEasJ1gEH0+4Wl2o/PRS8wz+zi0gLUCODD2fPAwoTpRvp5crfv24CWf36FEpXNz/G9s2joAACRQfy+K3DRfALRHb5zjQ8+OgjyD4inf+UA7awEcBxgDpqW3BhhEyMOmBywfQCJ76NL1rOONmk3pKiRTP4/GmQ54iUCn2Kc3nMJtUnUxWR3MN0VdaoQbcC4pBgLFmyHJJ6dUgu4Z2V4YB6e1l1LiuwObLupKsDKly1iNgCQQtX6F3AgdGFfKh38YmrkNDadULUqFGkiJeuNef2Lea/5s5x6+yYsc169zTqdPRNbNnWZy+bBOvUzuZhg2UbBsU3cUbSek1HbgzZY+4etUvGzqxScOcxs2nvFh1c0YWZi0eTG/6tOGiGzcU81536tvLlsEnJJW2RMXZE2qGFFx86uWfz59XVt++dfnt+CxhMQcVc/YH3Hj7cHZf/CW/5tcUcfc4hGB1/0x2iADwFXIQRgXQYiEuE9+EHoWYOoifiiCAGpBhpGixAEUUDUrhXajGaEJ9xEpYIXnEJKvigjp/xmJZfG8b0DgQKWMcPcD3NSByQONqC24koflXeU1RWmR5jzkwAQSqlTUOjEh1y9eF8Ofoy5Zkh/qgmSwsSiYwEBRwJwQUZ8hOnVWS6YuZ+aHbi5ps+pimobXCKOcYEdz7AQJI26YkSn5bY2N2ghAaq359sFqopZ9L5VgE8DFgAI5O0JNqUn5cCipChh2Lq6qvIoRepLBpQUaqpqKHq5Kw9xmrVjiRGaWWDWMZl6yoV5DqIBgU4MEIFDLyz/wAOyl476UirfhosSsOO912nV66JH7aPXDBqA2xYCK0IDWAIgAN0NpYoXqrBxy2s3pIBLrKEXatvQaAyNqcDEExLgSDwRgvAAgU84DDEAExmj73aYiUwrcUyCF24/Bb2JLJDprrFRCJ8yQbDKBdg7cMRV3waV2hRQxllGBjrcbkp5izfzlma6Om+tZaMxQUUTEEB0taKsbLEEb9c76mSbICA1VdjvYGUvyolbqbk/hxX0GCzyvG5irR7IZ5OOA2vKhTQW+PFH7cqrMhhi90m2WXz3LHOm5pb9BUauOiiISZfuO601V47979bCz0wyAFz3XXdFVOWgcbAEu2bb2dvg/83wI1tbnnd31aelkgCdBCB66+/3kHpQv4BuufkOC465HsPzfHYfwPuUo0RHFC88cZHMHtftQt++wlL8qp7zz7z3ffvhz1+LfHHH5/83cFL1fwTFkAgQflgWjw1+HmPeyzefl1PffVAo7A998V7zzXtKjL2MJ1I7mpmdPOd3ngnudP1K3XkaYz97pe/yG0scL7hkpfW5pHcrQ9+BXRfBjXYPuxJj4H3Q57yEEWaOdXpTgEcyAA59TUDRtB6GwRhBlfXQO49EIacM5v4mrAoBTTqURrC4PzY90IOFtGIstLhDmWogxt2r4QEY4yo3kGqFVKKWC5cIhP3Nz1LJdGGI8T/nxQn5DlcLUBXGIGeALPnNxp2C4Ehg2AM6ffEMR4gh0iMIw99owFd/RF9MsMC5iqjRSceEXh83GIhK+OvEA4Pj3pUZO8kSBogosyC32CKAFjTmrG8xo3xk18lEQmI1sEulbJToNeUAEUSfi+JJGOMBhTAAGfYUpPw4eQja7i7PZZSeHeUZC/DGAsBvJKMsVxk32w3BghcqAAMqAAW7UbHJgrzg3AMph1dicc8FpOZ3fTmGCe5zQP2sWAXqIIErFBN1F3TdFukmM0cuUxuKhGZ3zTnjVpoSkAkE5z3RKcl+0etd+gSH7xkZbBYl0rYrVJ/yzOFPonJ0LpVdIT87Of7/5g3wQlgiAENU1KYRglGcSoRoBaV6ILqt89w4lOM5Sxj5wrWsgJI4AIjnQcbE0nKmB4zoBs9KUFNmVGNwrSo41TpTAdaxyw5cwwoBOJ6qqInG/FInv88Kg5pSsCmBFSg8VRdUFd6TS9qaTEKcIA7CiDEPC10rAuMZFNZ2kqudvWiXwWrWbs40d74ZgFMs+ocGnmUpD7Vg3yt61n/SlfGAhOo2utrZBM7S+c5DIsOfWjsEIvNpeIVlnaNVWhFy0StZnOxSHXqZ6HaQxykImIWWIZmw7rRrJJ1spCtbGvzaVvPoha0QvVqQelSxQJQgFoKW2NJh7nbcyo1paUVa2Nb6v/c1cq1lUzFbnWnSJcHdCldbnUnSdN3XQcCN7cifC50e6vY7XKXt72VaXzli9aobiEV5msZealyjOlSV77Ble5wWTtg375Ur/Oc7lCD5Fj8YqGtaqttgrPb0AKPtlUAvu0hU0vO+lIyusl6rQkkHA8KU7a98y0re39q2YNsOL1zdWmLOdpBjxasnTqmy39/q+CtYri7pPWxhTEaZL+aELPLOuhgUTCHGP/Yw/DNa4b3OmUqn1a9j0Wvge9L4qq4TV5xczKNa4zbGZ83il12bJlB7OLE0pfLVS6ukg8RtajFrGZHQSVnI9ABT36SAx4wAKELbWgDeKBqWFv0BvScOT7/P/TPnyyLoA996EQvOtONrmcGIB1pQLtm0JY2NKYzfbVNc9rTEAV1qEdd6FKb2mqoHmSdB+EOl00sz/XcNa977etfZ8DRvx42sYEt7GIjO9lHObaymz1sWteaDXeemNyiTWZrpzXaEMbFl6kSZrhBQGrYBmytt82VbjsH3TZZXMsaN25y19ncrlA3Heh9O3nPe9z4Hom96/Lueeyb3/rut1UIjhKDMwYDOHu3wsfdcIcvHNsP/zfFK27xi2M84xrfOMc77vGPgzzkIh85yUtu8o5LYAoAkEC7usSyArhczIxjw7xmzm6m+c9dJsh5w9JGbYnh1Ak1b/ecLhRun0es/wQ8F0EFQIrcUjWgXTsVhAKaLAKWv8PlEhg6025+cuc1YF4uD/vKGcCApwFgAgywggNKZaHDiaHtAHh7mOcV7gfcvd0lwDsAbj33MYsAmtTq7wnk/vai99dC4YZt3tMIcwCIKlpqj8LPBeEOAJGA7BIwOwDSZS2QNqDugP+6ceGmAGqWwAKDt7uYFy8CxVeITtNOugjSRXsT2P7v76CAFVT/n6BfQfFFf0fS08b7HOQepBdwRwXCHOZHNMqtagSA6nH6sKo7A+1RI71ein77EczWXRZaF+tFALcJHOL8fW/39oHeAGgSnybvWNcI0nUBCSwKAIO/gvpJYCHU155bwf/fz/nPuuQcBbyfuzyfJVjISIVfwzhdu/ld+3HfXFSA6QEg5CEU29EL6zUASDEA/Y3BB0qTAU5M1EgA3OhdCaTgzI0ANDlAzsED4ZUACYbg3q0gAMCgCbRgu8GLwjzMBDhfvEAftVyArlSRAnDgH/3f7FUgY4QdzIWb/xzf0+Df2sELhohg0yAU/X0bvVDLNOFAGKJeCpaK55HA/uVAFioA/UFAzxVAA5hh5+WgCJChCDyLKsAL+k0eBaKCNN0eFboT3FDTvDRfvIDbE56QysmgBGZduGUhPEzdE0TiO0SL1+nfhZxdCRyUFQGACtahGuJAJUKLBTjdBKAeKFqdHWr/osMcFAVAndQ9QtXtXDSlkQoyQNcxmSLyYi/64i8CYzAK4zASYzEa4zEiYzIq4zIyYzM64zNCYzRK4zRSYzVa4zViYzaewpxsYhNwHlV8Iwmki+sJgkSUQPmdYwFkoDYOowXgogVw4xOEoxOI4hjMow5WnsrUod0toAhMAPqxIzFeYbi9YTzSYzfSI/CxwT0mFw2KQaMQHj8SofytY0D6oqg8CjfCzQ2yW8Nw3tY94vpZ4tA9AEhK4d/xY7vAov4hpP4tF0pWi+lxoDSNWf4FIE1CQD9Sn85ZJDD63QjE48M4QJhFDefZnQVI4URmIgdCAFKiX9pAwOTlIUuSAFIm/8nbPQv6pUsFCGXrBV4BHE5XSiSeMEBC9eTXPUxGShM+xuDEQJMqcF4nvkMPttv+ySVOjR8AhBnizaNVjsD4hdmtzYu1lJ8DAOT6ESad6KT+meVZmtxA6qADxCMMEuXEGKU6mgA0oR+1lIoh+l8c+uPaTeU9MsBLAma83FrUJCJSDpZqKqZS7uQkOuYTuqMVweNa7iC7WcdHDl0uxsMUEp9JrmVe6qVKlgpDrt3rxWFg8tdGwt5/9JdzvmbiSExFzuZ1rgI0fV8T4F8BlMoEyOYT/CN2kqc2jKMTDJ8YPgs5YoFnlud7wmd8yud80md92ud94md+6ud+8md/+ud/Ai1ogArogBJogRrogSJogirogjJogzrog0JohErohFJohVrohWJohmrohl5cCAAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is a direct relationship between cholesterol level and mortality among patients without coronary heart disease (CHD) and those with CHD and angina or myocardial infarction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Rosengren, A, Hagman, M, Wedel, H, et al. Eur Heart J 1997; 18:754.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23120=[""].join("\n");
var outline_f22_37_23120=null;
var title_f22_37_23121="Planter fascia stretching exercise";
var content_f22_37_23121=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Planter fascia stretching exercise",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 411px; height: 524px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plantar fascia-stretching exercise. The patient crosses the affected leg over the contralateral leg. While placing the fingers across the base of the toes, the patient pulls the toes back toward the shin until he or she felt a stretch in the arch or plantar fascia. The patient confirms that the stretch is correct by palpating tension in the plantar fascia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23121=[""].join("\n");
var outline_f22_37_23121=null;
var title_f22_37_23122="Nedocromil: Pediatric drug information";
var content_f22_37_23122=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Nedocromil: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?0/43/691?source=see_link\">",
"    see \"Nedocromil: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?7/41/7828?source=see_link\">",
"    see \"Nedocromil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F200225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alocril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F200226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alocril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiallergic, Ophthalmic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/43/691?source=see_link\">",
"      see \"Nedocromil: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Ophthalmic: Children &ge;3 years and Adults: 1-2 drops in each eye twice daily throughout the period of exposure to allergen",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F200207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as sodium [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alocril&reg;: 2% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F200196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Ophthalmic: Instill drops into conjunctival sac; avoid contact of bottle tip with skin or eye",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1060521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 2&deg;C to 25&deg;C (36&deg;F to 77&deg;F); the remaining contents of Alocril&reg; unit dose solution should be discarded immediately after use",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Treatment of itching associated with allergic conjunctivitis (FDA approved in ages &ge;3 years and adults)",
"    </p>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F200263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Unpleasant taste",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Burning, conjunctivitis, eye redness, irritation, photophobia, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Asthma, nasal congestion, rhinitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060532\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to nedocromil or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Contains benzalkonium chloride, which may be absorbed by contact lenses; users of contact lenses should not wear them during periods of symptomatic allergic conjunctivitis.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F200204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5282499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no well-controlled studies in pregnant women. Animal studies show no evidence of teratogenicity or harm to fetus. Additionally, nedocromil has minimal systemic absorption.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060516\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits the activation of and mediator release from a variety of inflammatory cell types associated with hypersensitivity reactions, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets; inhibits the release of histamine, leukotrienes, and slow-reacting substance of anaphylaxis",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Systemic: Ophthalmic: &lt;4%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Excreted unchanged in urine 70%; feces 30%",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12632 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-BCBD45DDC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23122=[""].join("\n");
var outline_f22_37_23122=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200225\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200226\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060524\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060519\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200207\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200196\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060528\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060521\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060527\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200263\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060532\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060518\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299748\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221824\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F200204\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5282499\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060516\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060531\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12632\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12632|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/43/691?source=related_link\">",
"      Nedocromil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?7/41/7828?source=related_link\">",
"      Nedocromil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_37_23123="Tachycardia overview algorithm";
var content_f22_37_23123=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78734&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78734&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    The tachycardia overview algorithm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 664px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2000 I-159.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23123=[""].join("\n");
var outline_f22_37_23123=null;
var title_f22_37_23124="Iodixanol: Pediatric drug information";
var content_f22_37_23124=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Iodixanol: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?12/63/13301?source=see_link\">",
"    see \"Iodixanol: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/35/16948?source=see_link\">",
"    see \"Iodixanol: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Visipaque&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9746694\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Visipaque&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1019840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Radiological/Contrast Media, Nonionic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F4150480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/63/13301?source=see_link\">",
"      see \"Iodixanol: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The concentration and volume of iodixanol to be used should be individualized depending upon age, weight, size of vessel, and rate of blood flow within the vessel.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Children &gt;1 year:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Intra-arterial: Cerebral, cardiac chambers and related major arteries, and visceral studies:",
"     <b>",
"      320 mg iodine/mL",
"     </b>",
"     : 1-2 mL/kg; not to exceed 4 mL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V.: Contrast-enhanced computerized tomography or excretory urography:",
"     <b>",
"      270 mg iodine/mL",
"     </b>",
"     : 1-2 mL/kg; not to exceed 2 mL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &gt;12 years and Adults: Maximum recommended total dose of iodine: 80 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Intra-arterial: Iodixanol",
"     <b>",
"      320 mg iodine/mL",
"     </b>",
"     : Dose individualized based on injection site and study type; refer to product labeling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     I.V.: Iodixanol",
"     <b>",
"      270 mg and 320 mg iodine/mL",
"     </b>",
"     : concentration and dose vary based on study type; refer to product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Not studied; use caution",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F183718\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Visipaque&trade;: 270: 550 mg/mL (50 mL, 100 mL, 125 mL [DSC], 150 mL, 200 mL, 500 mL [DSC]) [contains edetate calcium disodium; provides organically-bound iodine 270 mg/mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Visipaque&trade;: 320: 652 mg/mL (50 mL, 100 mL, 150 mL, 200 mL, 500 mL) [contains edetate calcium disodium; provides organically-bound iodine 320 mg/mL]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F183714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F2529683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V. or intra-arterial: Administer without further dilution.",
"     <b>",
"      Not for intrathecal administration",
"     </b>",
"     . Avoid extravasation.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F13791578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Fenoldopam.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1019847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature; do not mix with or inject in I.V. lines with other medications, solutions, or TPN solutions",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1019841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Nonionic contrast media for radiological use intra-arterially: Digital subtraction angiography; angiocardiography (left ventriculography and selective coronary arteriography), peripheral arteriography, visceral arteriography, and cerebralarteriography. Intravenously: Contrast enhanced computed tomography (CECT) imaging of the head and body, excretory urography, and peripheral venography",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2087642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       <b>",
"        Not",
"       </b>",
"       for intrathecal use.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F2087648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Angina/chest pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Headache/migraine, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Nonurticarial rash/erythema, pruritus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Nausea, taste perversion,",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Local: Injection site reactions (discomfort/pain/warmth)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Parosoma",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rare but important or life-threatening: Acute renal failure, anaphylactoid reaction, anaphylaxis, apnea (children only), arrhythmia (children only), asthma, AV block (children only), back pain, bundle branch block (children only), cardiac arrest, cardiac failure (children only), cerebral vascular disorder, disseminated intravascular coagulation (children only), hematoma, hemorrhage, hypersensitivity, hypertension, hypoglycemia, hypotensive collapse, peripheral ischemia, pharyngeal edema, pulmonary edema, pulmonary embolism, respiratory depression, seizure, shock",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1019846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to iodixanol or any component; intrathecal administration; administration to children who have experienced prolonged fasting or received recent laxative dose(s)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F4150189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in pediatric patients with asthma, hypersensitivity to other medication and/or allergens, cyanotic and acyanotic heart disease, CHF, serum creatinine &gt;1.5 mg/dL, and neonates (immature renal function) due to an increased risk of adverse effects with iodixanol. Dehydration, particularly in children, may also increase the risk of adverse effects. Patients should be adequately hydrated both prior to and after iodixanol administration. In pediatric patients, apnea, arrhythmias (AV block, bundle branch block), cardiac failure, disseminated intravascular coagulation, and taste perversion have been reported. Use caution in thyroid disease; thyroid storm has been reported in patients with history of hyperthyroidism.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2529660\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.V. or intra-arterial use only;",
"     <b>",
"      may be fatal if given intrathecally [U.S. Boxed Warning]",
"     </b>",
"     ; intrathecal injection has also resulted in serious reactions (seizures, cerebral hemorrhage, coma, paralysis, arachnoiditis, ARF, cardiac arrest, rhabdomyolysis, hyperthermia, and brain edema). May cause rare but serious thromboembolic events including MI and stroke. Iodinated contrast media has been associated with severe hypersensitivity reactions including anaphylaxis; immediate treatment for anaphylactic reactions should be available during administration of iodixanol. Use with extreme caution in patients with or suspected of having pheochromocytoma; the amount of iodixanol used should be kept to an absolute minimum and blood pressure should be closely monitored throughout the procedure in these patients. Contrast media when administered intravascularly may promote sickling in patients who are homozygous for sickle cell disease. May worsen renal insufficiency in patients with multiple myeloma. Avoid use in patients with homocystinuria due to the risk of inducing thrombosis and embolism. Avoid extravasation.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F2087653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Contrast Media (Non-ionic) may enhance the potential for allergic or hypersensitivity reactions to Aldesleukin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetFORMIN: Iodinated Contrast Agents may enhance the adverse/toxic effect of MetFORMIN. Renal dysfunction that may be caused by iodinated contrast agents may lead to metformin-associated lactic acidosis.  Management: Withhold metformin from all patients receiving intravascular iodinated contrast agents prior to or at the time of the procedure and for at least 48 hrs thereafter.  Document adequate renal function before restarting metformin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F183716\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F183723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Fetal harm was not observed in animal studies. There are no adequate and well-controlled studies in pregnant women. In general, iodinated contrast media agents are avoided during pregnancy unless essential for diagnosis.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F4150481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor signs and symptoms of hypersensitivity reactions",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F4150477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Iodixanol is a nonionic, isosmolar, water soluble, iodinated x-ray contrast media for intravascular administration. It opacifies vessels in the path of flow permitting radiographic visualization of internal structures.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F4150478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Following administration, the increase in tissue density is related to blood flow, the concentration of the iodixanol solution used, and the extraction of iodixanol by various interstitial tissues. The degree of enhancement is directly related to the iodine content in an administered dose.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Kidney:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Visualization: Renal parenchyma: 30-60 seconds; calyces and pelves (normal renal function): 1-3 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Optimum contrast: 5-15 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F4150479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Adults: 0.26 L/kg",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Metabolism: Metabolites have not been identified.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Time to peak level: I.V.: Children: 0.75-1.25 hours",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Newborns to Infants &lt;2 months: 4.1 &plusmn; 1.4 hours",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Infants 2-6 months: 2.8 &plusmn; 0.6 hours",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Infants 6-12 months: 2.4 &plusmn; 0.4 hours",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Children 1 to &lt;3 years: 2.2 &plusmn; 0.5 hours",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Children 3 to &lt;12 years: 2.3 &plusmn; 0.5 hours",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Adults: 2.1 &plusmn; 0.1 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Elimination: 97% excreted unchanged in the urine within 24 hours; &lt;2% excreted in feces",
"    </p>",
"    <p style=\"text-indent:2em;\">",
"     Clearance:  Adults: 110 mL/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dialysis: Dialyzable (36% to 49% depending upon the membrane)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F4150483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/35/16948?source=see_link\">",
"      see \"Iodixanol: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inform healthcare provider if you are allergic to any drugs or food, or if you have had any reactions to previous injections of dyes used for x-ray procedures.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Johnson WH, Lloyd TR, Victorica BE, et al, &ldquo;Iodixanol Pharmacokinetics in Children,&rdquo;",
"      <i>",
"       Pediatr Cardiol",
"      </i>",
"      , 2001, 22(3):223-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?22/37/23124/abstract-text/11343148/pubmed\" id=\"11343148\" target=\"_blank\">",
"        11343148",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12989 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-D7E3B57AC3-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23124=[""].join("\n");
var outline_f22_37_23124=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708949\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183727\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9746694\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1019840\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150480\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183718\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183714\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529683\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13791578\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1019847\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1019841\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2087642\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2087648\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1019846\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150189\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2529660\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299528\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2087653\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183716\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183723\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150481\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150477\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150478\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150479\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4150483\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12989\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12989|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/63/13301?source=related_link\">",
"      Iodixanol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/35/16948?source=related_link\">",
"      Iodixanol: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_37_23125="Jarvik 2000 LVAD";
var content_f22_37_23125=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F86143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F86143&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    The Jarvik 2000 left ventricular assist device",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 573px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the intraventricular position of the device.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission. Copyright &copy; 2012 Jarvik Heart, Inc.",
"     <a href=\"file://www.jarvikheart.com/\" target=\"_blank\">",
"      www.jarvikheart.com/",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23125=[""].join("\n");
var outline_f22_37_23125=null;
var title_f22_37_23126="Leukocytoclastic vasculitis II";
var content_f22_37_23126=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F66296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F66296&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Leukocytoclastic vasculitis histology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Skin biopsy from a patient with leukocytoclastic vasculitis showing striking mural fibrin deposition in a postcapillary venule and a concomitant angiocentric mixed neutrophilic and lymphocytic infiltrate. This pattern can be seen in a variety of disorders including hypersensitivity vasculitis, systemic lupus erythematosus, rheumatoid arthritis, mixed connective tissue disease, Sj&ouml;gren's syndrome, Behcet's disease, and relapsing polychondritis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cynthia Magro, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23126=[""].join("\n");
var outline_f22_37_23126=null;
var title_f22_37_23127="Post-thrombotic (postphlebitic) syndrome";
var content_f22_37_23127=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Post-thrombotic (postphlebitic) syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Patrick C Alguire, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Barbara M Mathes, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23127/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23127/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/37/23127/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Post-thrombotic syndrome (PTS) is the development of chronic venous symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    signs secondary to deep venous thrombosis. This replaces the prior terminology \"postphlebitic syndrome\" [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/1\">",
"     1",
"    </a>",
"    ]. Injury to the venous valvular system produces symptoms of chronic venous insufficiency that can include pain, venous dilation, edema, pigmentation, skin changes, and venous ulcers. Development of post-thrombotic syndrome was the major factor impairing quality of life in a study of patients two years after deep venous thrombosis (DVT) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews the epidemiology and prevention of post-thrombotic syndrome. The management of patients with chronic venous insufficiency as a result of post-thrombotic syndrome is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Post-thrombotic syndrome affects 23 to 60 percent of patients following an episode of deep vein thrombosis (DVT) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/3\">",
"     3",
"    </a>",
"    ]. In a large prospective study of patients with an initial venographically-confirmed episode of deep venous thrombosis, the cumulative incidence of post-thrombotic syndrome at one, two, and five years was 17, 23, and 28 percent, respectively; these percentages did not increase thereafter [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/4\">",
"     4",
"    </a>",
"    ]. The incidence of severe skin changes indicative of chronic venous insufficiency, including venous ulcer, increased from 2.6 percent at one year to 9.3 percent at five years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most data regarding the natural history of chronic venous insufficiency are from prospective or cross-sectional studies of patients with acute deep venous thrombosis. There are conflicting reports regarding the risk of developing the post-thrombotic syndrome, but it is felt to be associated with several underlying factors which are presented below [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436298064\">",
"    <span class=\"h2\">",
"     Patient characteristics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Higher body mass index appears to be a risk factor for development of the post-thrombotic syndrome after DVT [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Age and gender were not noted to be significant risk factors in one review [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/5\">",
"     5",
"    </a>",
"    ], but a subsequent study found that increased age and female sex increased risk [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thrombophilia does not appear to increase the risk for developing post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/4,8,9\">",
"     4,8,9",
"    </a>",
"    ]. In one retrospective review of 677 patients, no significant differences in the incidence of post-thrombotic syndrome were seen between those patients with thrombophilia (antithrombin, protein C and S deficiencies, lupus anticoagulant, Factor V Leiden) compared with those without thrombophilia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Characteristics of the DVT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1060405\">",
"    <span class=\"h3\">",
"     Symptomatic or asymptomatic",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of post-thrombotic syndrome is probably much lower after asymptomatic DVT, such as those detected on postoperative screening [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/10\">",
"     10",
"    </a>",
"    ]. A systematic review concluded that asymptomatic postoperative DVT still substantially increases the risk of post-thrombotic syndrome; however, there was evidence of significant publication bias in the review [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1060231\">",
"    <span class=\"h3\">",
"     Proximal or distal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have found the absolute risk of trophic skin changes following venous thrombosis to be greatest with proximal as compared with distal thrombosis, and with deep or deep and superficial thrombosis as compared with only superficial thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/6,12-18\">",
"     6,12-18",
"    </a>",
"    ]. However, other studies have not demonstrated a greater risk for proximal over distal thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/4,19\">",
"     4,19",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Clinical manifestations and diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436299001\">",
"    <span class=\"h3\">",
"     Primary or recurrent DVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of recurrent ipsilateral DVT is strongly associated with the risk for the post-thrombotic syndrome (hazard ratio 6.4) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/4,6,20,21\">",
"     4,6,20,21",
"    </a>",
"    ]. This suggests that prevention of recurrent thrombosis is the most important intervention in patients presenting with DVT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=see_link&amp;anchor=H31#H31\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'Recurrent VTE'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Venous reflux",
"    </span>",
"    &nbsp;&mdash;&nbsp;A combination of reflux due to valvular incompetence, and venous hypertension due to thrombotic obstruction, is thought to contribute to the risk of post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/22\">",
"     22",
"    </a>",
"    ]. One study identified a high peak reflux velocity in the deep proximal veins as an independent predictor of post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43365?source=see_link&amp;anchor=H4#H4\">",
"     \"Pathophysiology of chronic venous disease\", section on 'Genesis and consequences of chronic venous hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436298591\">",
"    <span class=\"h2\">",
"     DVT treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minimizing the development of post-thrombotic syndrome is related to timely and adequate pharmacologic treatment of deep vein thrombosis when it occurs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436298634\">",
"    <span class=\"h3\">",
"     Choice of anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of post-thrombotic syndrome is greater in patients who do not maintain adequate anticoagulation during initial treatment for their DVT. In one study comparing patients whose INR was subtherapeutic (&lt;2.0) with those whose INR was &ge;2.0 for more than 50 percent of readings in the first three months of treatment, the odds ratio for risk of the post-thrombotic syndrome was 2.71 (95% CI 1.44-5.10) over five-year follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/8\">",
"     8",
"    </a>",
"    ]. The duration of long-term anticoagulation beyond initial treatment did not correlate with occurrence of the post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of developing venous ulceration may be lower in patients treated with low-molecular-weight",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    compared with oral anticoagulation, which could be due to more consistent anticoagulation. A pooled analysis of two trials found a lower risk of self-reported skin ulcers in patients treated with low-molecular-weight heparin (risk ratio 0.13, 95% CI 0.02-0.71) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/24\">",
"     24",
"    </a>",
"    ]. Vein recanalization rates following deep vein thrombosis were also higher in patients receiving low-molecular-weight heparin. Anticoagulation for the treatment of deep vein thrombosis is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=see_link\">",
"     \"Treatment of lower extremity deep vein thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436298244\">",
"    <span class=\"h3\">",
"     Thrombolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of thrombolytic therapy to treat acute proximal DVT may decrease the risk of post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/25\">",
"     25",
"    </a>",
"    ]; however, it is not clear whether the benefits outweigh the risks involved. This is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28697?source=see_link&amp;anchor=H17#H17\">",
"     \"Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis\", section on 'Lower extremity deep vein thrombosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of chronic venous insufficiency are discussed in detail separately. Summarized briefly, symptoms can include pain, venous dilation, edema, pigmentation, skin changes and venous ulcers. Edema occurs in approximately two-thirds of patients with post-thrombotic syndrome, skin pigmentation in about one-third, and venous ulceration in less than 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/4,12,13,22,26,27\">",
"     4,12,13,22,26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=see_link\">",
"     \"Clinical evaluation of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical severity of post-thrombotic syndrome (PTS) is best estimated using the Villalta score, which is a score that combines patient limb symptoms and signs in a graded scoring system [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/27\">",
"     27",
"    </a>",
"    ]. A higher score indicates a greater severity of PTS with a score of &gt;15 suggesting severe PTS. The Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification is also useful for characterizing chronic venous disease. Classification systems used in the diagnosis and management of lower extremity chronic venous disease are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11735?source=see_link&amp;anchor=H35#H35\">",
"     \"Classification of lower extremity chronic venous disorders\", section on 'Villalta scale'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11735?source=see_link&amp;anchor=H6#H6\">",
"     \"Classification of lower extremity chronic venous disorders\", section on 'CEAP classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It may be worth investigating whether the patient has a residual iliac stenosis or occlusion or proximal venous reflux that may benefit from intervention. Venous duplex and intravascular ultrasound along with venography are the main imaging modalities for assessing for obstruction or venous reflux in patients with PTS. The general approach to the diagnostic evaluation of chronic venous insufficiency is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/43/33462?source=see_link\">",
"     \"Diagnostic evaluation of chronic venous insufficiency\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H436299075\">",
"     'Interventions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Post-thrombotic syndrome has a significant negative effect on quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/2,28-30\">",
"     2,28-30",
"    </a>",
"    ]. Trophic changes tend to occur between two and four years after DVT, with no further changes between five and twelve years [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/4,22\">",
"     4,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436298483\">",
"    <span class=\"h2\">",
"     D-Dimer",
"    </span>",
"    &nbsp;&mdash;&nbsp;D-dimers are detectable at levels greater than 500",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (ie, 500",
"    <span class=\"nowrap\">",
"     mcg/L)",
"    </span>",
"    of fibrinogen equivalent units in nearly all patients with venous thromboembolism. Elevated D-dimer measured off oral anticoagulants is also predictive of recurrent venous thromboembolism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/12/33994?source=see_link&amp;anchor=H21#H21\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'D-dimer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=see_link&amp;anchor=H34#H34\">",
"     \"Treatment of lower extremity deep vein thrombosis\", section on 'D-dimer levels'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An elevated D-dimer level may signal persistent activation of clotting or inflammatory pathways increasing the propensity to develop post-thrombotic syndrome and, thus, D-dimer is thought by some to be a predictor of post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/18,33\">",
"     18,33",
"    </a>",
"    ]. In one of these studies, 45 percent of 305 patients with acute symptomatic DVT developed post-thrombotic syndrome as determined by the Villalta scale. Mean D-dimer at four months follow-up was significantly higher in patients who developed post-thrombotic syndrome compared with those who did not (712 versus 444",
"    <span class=\"nowrap\">",
"     mcg/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/33\">",
"     33",
"    </a>",
"    ]. D-dimer levels were affected by",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    administration with lower levels seen in patients (with or without PTS) taking warfarin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11735?source=see_link&amp;anchor=H35#H35\">",
"     \"Classification of lower extremity chronic venous disorders\", section on 'Villalta scale'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of patients with venous insufficiency as a result of post-thrombotic syndrome is similar to that of other patients with chronic venous disease and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link\">",
"     \"Medical management of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436298802\">",
"    <span class=\"h2\">",
"     Compression therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review and metaanalysis of randomized trials found that graded compression stockings are effective in reducing the incidence of post-thrombotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/34\">",
"     34",
"    </a>",
"    ]. The metaanalysis included five trials and 338 patients. Postthrombotic syndrome developed in 26 percent of patients treated with compression stockings compared with 46 percent of control patients, resulting in a 54 percent relative risk reduction (95% CI, 0.44-0.67).",
"   </p>",
"   <p>",
"    There were methodologic differences between the five included trials with respect to timing of the intervention, nature of the control and differences in criteria for diagnosis of post-thrombotic syndrome (",
"    <a class=\"graphic graphic_table graphicRef52292 \" href=\"UTD.htm?16/32/16910\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. The lowest risk of developing post-thrombotic syndrome is associated with earlier use of stockings [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two trials showed no differences in the incidence of skin changes between patients who wore compression stockings and those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/10,35\">",
"     10,35",
"    </a>",
"    ]. However, patients in these two studies were not randomized to wear stockings until six months and one year after the diagnosis of DVT. In one of these trials, many of the patients included had asymptomatic DVT detected by screening after orthopedic procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, control patients were treated with a placebo stocking (one or two sizes too large).",
"   </p>",
"   <p>",
"    The use of compression stockings for the control of lower extremity venous symptoms and compression bandaging to manage lower extremity venous ulceration are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link&amp;anchor=H7#H7\">",
"     \"Medical management of lower extremity chronic venous disease\", section on 'Graduated compression stockings'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9079?source=see_link\">",
"     \"Compression bandaging for chronic venous insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H375853153\">",
"    <span class=\"h3\">",
"     Symptomatic DVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with symptomatic proximal DVT, the weight of evidence supports the use of knee-high graduated compression stockings exerting a pressure of 30 to 40 mmHg at the ankle (",
"    <a class=\"graphic graphic_table graphicRef74574 \" href=\"UTD.htm?36/42/37547\">",
"     table 2",
"    </a>",
"    ). The appropriate duration of use is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/40\">",
"     40",
"    </a>",
"    ], but we recommend the use of stockings for at least one year and possibly up to two years after DVT. Guidelines from the American College of Physicians and the American Academy of Family Physicians recommend use of compression stockings started within one month of proximal DVT, and continued for a minimum of one year after diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/41\">",
"     41",
"    </a>",
"    ]. Use of compression stockings is contraindicated in patients with evidence of severe occlusive arterial disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=see_link&amp;anchor=H9#H9\">",
"     \"Medical management of lower extremity chronic venous disease\", section on 'Use and care of compression stockings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H375853012\">",
"    <span class=\"h3\">",
"     Asymptomatic DVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the differing strengths and weaknesses of the individual trials, the evidence for compression stockings for prevention of post-thrombotic syndrome for asymptomatic patients is not definitive. The rates of post-thrombotic syndrome after asymptomatic DVT are so low that compression stockings may be of little value.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H436299075\">",
"    <span class=\"h2\">",
"     Interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early endovascular or surgical interventions in appropriately selected patients with venous obstruction or reflux may decrease the incidence of recurrent ulceration and skin changes and improve quality-of-life in patients with post-thrombotic syndrome. If venous obstruction is present, it is addressed first",
"   </p>",
"   <p>",
"    Occluded or stenotic iliac vein segments can be treated using percutaneous angioplasty with or without stenting, venous bypass or endophlebectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/27,42\">",
"     27,42",
"    </a>",
"    ]. Surgical options are selectively performed only after failed percutaneous attempts to restore flow. In a study of 44 patients (of which 8 patients had PTS), the technical success rate for iliac venous stenting was 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/43\">",
"     43",
"    </a>",
"    ]. Venous clinical severity scores in treated patients were improved from a median score of 8.5 to 2, and the median venous disability score improved from 2 to 0. Primary, assisted primary, and secondary patency rates of the treated venous segments at three years were 73, 88, and 90 percent, respectively. The results were not stratified by the etiology of the venous disease.",
"   </p>",
"   <p>",
"    For patients with severe proximal venous reflux, vein valve surgery has been performed but is limited to certain high-volume referral centers [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23127/abstract/42,44-46\">",
"     42,44-46",
"    </a>",
"    ]. Valvuloplasty is used for incompetent but intact deep vein valves, while neovalve creation, valve transposition, axillary vein autotransplantation or prosthetic vein valves are techniques used to manage destroyed valves. Venous valve reconstruction (including valve transplant, valvuloplasty, and endograft valves) has been largely unsuccessful in the treatment of these patients and abandoned by many of the original advocates.",
"   </p>",
"   <p>",
"    Focal symptoms and patients with venous ulceration may benefit from treatment of incompetent superficial veins. Ablation procedures are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13514?source=see_link\">",
"     \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30809?source=see_link\">",
"     \"Radiofrequency ablation for the treatment of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/34/30250?source=see_link\">",
"     \"Endovenous laser ablation for the treatment of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/29/21977?source=see_link\">",
"     \"Open surgical techniques for lower extremity vein ablation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Post-thrombotic syndrome is the development of symptoms of venous insufficiency following deep venous thrombosis (DVT). Post-thrombotic syndrome occurs in about 23 to 60 percent of patients who have had a symptomatic DVT (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Symptoms can include pain, venous dilation, edema, pigmentation, skin changes and venous ulcers. Post-thrombotic syndrome has a significant negative effect on quality of life (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Thrombolytic therapy for acute proximal DVT may decrease the risk of post-thrombotic syndrome, but is associated with certain risks. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28697?source=see_link&amp;anchor=H17#H17\">",
"       \"Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis\", section on 'Lower extremity deep vein thrombosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with symptomatic DVT, we recommend knee-high graduated compression stockings exerting a pressure of at least 30 to 40 mmHg at the ankle for at least one year after DVT (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The rate of post-thrombotic syndrome after asymptomatic DVT appears to be so low that compression stockings may be of little value. Compression therapy is contraindicated in patients with evidence of severe occlusive arterial disease.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/1\">",
"      Porter JM, Moneta GL. Reporting standards in venous disease: an update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995; 21:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/2\">",
"      Kahn SR, Shbaklo H, Lamping DL, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost 2008; 6:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/3\">",
"      Ashrani AA, Heit JA. Incidence and cost burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009; 28:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/4\">",
"      Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/5\">",
"      Kahn SR. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol 2006; 134:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/6\">",
"      Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/7\">",
"      Ageno W, Piantanida E, Dentali F, et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost 2003; 89:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/8\">",
"      van Dongen CJ, Prandoni P, Frulla M, et al. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost 2005; 3:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/9\">",
"      Spiezia L, Campello E, Giolo E, et al. Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation. J Thromb Haemost 2010; 8:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/10\">",
"      Ginsberg JS, Hirsh J, Julian J, et al. Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001; 161:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/11\">",
"      Wille-J&oslash;rgensen P, Jorgensen LN, Crawford M. Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost 2005; 93:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/12\">",
"      Strandness DE Jr, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/13\">",
"      Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. J Vasc Surg 1995; 21:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/14\">",
"      van Ramshorst B, van Bemmelen PS, Hoeneveld H, Eikelboom BC. The development of valvular incompetence after deep vein thrombosis: a follow-up study with duplex scanning. J Vasc Surg 1994; 19:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/15\">",
"      McEnroe CS, O'Donnell TF Jr, Mackey WC. Correlation of clinical findings with venous hemodynamics in 386 patients with chronic venous insufficiency. Am J Surg 1988; 156:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/16\">",
"      Sethia KK, Darke SG. Long saphenous incompetence as a cause of venous ulceration. Br J Surg 1984; 71:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/17\">",
"      Labropoulos N, Leon M, Geroulakos G, et al. Venous hemodynamic abnormalities in patients with leg ulceration. Am J Surg 1995; 169:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/18\">",
"      Stain M, Sch&ouml;nauer V, Minar E, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005; 3:2671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/19\">",
"      Philbrick JT, Becker DM. Calf deep venous thrombosis. A wolf in sheep's clothing? Arch Intern Med 1988; 148:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/20\">",
"      Labropoulos N, Jen J, Jen H, et al. Recurrent deep vein thrombosis: long-term incidence and natural history. Ann Surg 2010; 251:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/21\">",
"      Labropoulos N, Gasparis AP, Tassiopoulos AK. Prospective evaluation of the clinical deterioration in post-thrombotic limbs. J Vasc Surg 2009; 50:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/22\">",
"      Franzeck UK, Schalch I, J&auml;ger KA, et al. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Z&uuml;rich study). Circulation 1996; 93:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/23\">",
"      Yamaki T, Nozaki M, Sakurai H, et al. High peak reflux velocity in the proximal deep veins is a strong predictor of advanced post-thrombotic sequelae. J Thromb Haemost 2007; 5:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/24\">",
"      Hull RD, Liang J, Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med 2011; 124:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/25\">",
"      Enden T, Haig Y, Kl&oslash;w NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/26\">",
"      Heldal M, Seem E, Sandset PM, Abildgaard U. Deep vein thrombosis: a 7-year follow-up study. J Intern Med 1993; 234:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/27\">",
"      Henke PK, Comerota AJ. An update on etiology, prevention, and therapy of postthrombotic syndrome. J Vasc Surg 2011; 53:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/28\">",
"      Kahn SR, Hirsch A, Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/29\">",
"      Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004; 164:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/30\">",
"      Ashrani AA, Silverstein MD, Rooke TW, et al. Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study. Vasc Med 2010; 15:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/31\">",
"      Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008; 149:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/32\">",
"      Cosmi B, Legnani C, Tosetto A, et al. Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension. J Thromb Haemost 2010; 8:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/33\">",
"      Latella J, Desmarais S, Miron MJ, et al. Relation between D-dimer level, venous valvular reflux and the development of post-thrombotic syndrome after deep vein thrombosis. J Thromb Haemost 2010; 8:2169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/34\">",
"      Musani MH, Matta F, Yaekoub AY, et al. Venous compression for prevention of postthrombotic syndrome: a meta-analysis. Am J Med 2010; 123:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/35\">",
"      Aschwanden M, Jeanneret C, Koller MT, et al. Effect of prolonged treatment with compression stockings to prevent post-thrombotic sequelae: a randomized controlled trial. J Vasc Surg 2008; 47:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/36\">",
"      Ginsberg JS. Routine stocking therapy after deep venous thrombosis: a clinical dilemma. Ann Intern Med 2004; 141:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/37\">",
"      Brandjes DP, B&uuml;ller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/38\">",
"      Prandoni P, Lensing AW, Prins MH, et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med 2004; 141:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/39\">",
"      Partsch H, Kaulich M, Mayer W. Immediate mobilisation in acute vein thrombosis reduces post-thrombotic syndrome. Int Angiol 2004; 23:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/40\">",
"      Kolbach DN, Sandbrink MW, Hamulyak K, et al. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2004; :CD004174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/41\">",
"      Snow V, Qaseem A, Barry P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007; 146:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/42\">",
"      Khanna AK, Singh S. Postthrombotic syndrome: surgical possibilities. Thrombosis 2012; 2012:520604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/43\">",
"      Hartung O, Otero A, Boufi M, et al. Mid-term results of endovascular treatment for symptomatic chronic nonmalignant iliocaval venous occlusive disease. J Vasc Surg 2005; 42:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/44\">",
"      Raju S, Fredericks RK, Negl&egrave;n PN, Bass JD. Durability of venous valve reconstruction techniques for \"primary\" and postthrombotic reflux. J Vasc Surg 1996; 23:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/45\">",
"      Raju S, Negl&eacute;n P, Doolittle J, Meydrech EF. Axillary vein transfer in trabeculated postthrombotic veins. J Vasc Surg 1999; 29:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23127/abstract/46\">",
"      Bry JD, Muto PA, O'Donnell TF, Isaacson LA. The clinical and hemodynamic results after axillary-to-popliteal vein valve transplantation. J Vasc Surg 1995; 21:110.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8200 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-E4A1FE5218-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23127=[""].join("\n");
var outline_f22_37_23127=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H436298064\">",
"      Patient characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Characteristics of the DVT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1060405\">",
"      - Symptomatic or asymptomatic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1060231\">",
"      - Proximal or distal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H436299001\">",
"      - Primary or recurrent DVT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Venous reflux",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H436298591\">",
"      DVT treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H436298634\">",
"      - Choice of anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H436298244\">",
"      - Thrombolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H436298483\">",
"      D-Dimer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H436298802\">",
"      Compression therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H375853153\">",
"      - Symptomatic DVT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H375853012\">",
"      - Asymptomatic DVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H436299075\">",
"      Interventions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8200\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8200|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/32/16910\" title=\"table 1\">",
"      Do compression stockings prevent post-thrombotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/42/37547\" title=\"table 2\">",
"      Compression stockings in chronic venous disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11735?source=related_link\">",
"      Classification of lower extremity chronic venous disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=related_link\">",
"      Clinical evaluation of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/55/9079?source=related_link\">",
"      Compression bandaging for chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/12/33994?source=related_link\">",
"      Diagnosis of suspected deep vein thrombosis of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/43/33462?source=related_link\">",
"      Diagnostic evaluation of chronic venous insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/34/30250?source=related_link\">",
"      Endovenous laser ablation for the treatment of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/1/28697?source=related_link\">",
"      Fibrinolytic (thrombolytic) therapy in acute pulmonary embolism and lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13514?source=related_link\">",
"      Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32410?source=related_link\">",
"      Medical management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/29/21977?source=related_link\">",
"      Open surgical techniques for lower extremity vein ablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43365?source=related_link\">",
"      Pathophysiology of chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/5/30809?source=related_link\">",
"      Radiofrequency ablation for the treatment of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/4/43082?source=related_link\">",
"      Treatment of lower extremity deep vein thrombosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_37_23128="Differential diagnosis of sexual pain in women";
var content_f22_37_23128=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differential diagnosis of sexual pain in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23128/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23128/contributors\">",
"     Elizabeth Gunther Stewart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23128/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23128/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23128/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23128/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/37/23128/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with sexual pain disorders experience genital pain just before, during, or after sexual intercourse. There are many possible etiologies of pain related to sex (",
"    <a class=\"graphic graphic_table graphicRef59848 graphicRef70497 graphicRef50537 \" href=\"UTD.htm?36/27/37310\">",
"     table 1A-C",
"    </a>",
"    ). The leading cause in women under the age of 50 has been attributed to localized vulvodynia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/1\">",
"     1",
"    </a>",
"    ]. In women over the age of 50, urogenital atrophy is the leading cause [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women often do not bring this complaint to the attention of their health care providers. A study from Sweden reported only 28 percent of women with a history of prolonged and severe pain with sex consulted a physician for their symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review the most common etiologies of sexual pain disorders in women and their treatment. The initial diagnostic approach to sexual pain is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=see_link\">",
"     \"Approach to the woman with sexual pain\"",
"    </a>",
"    .) Male dyspareunia is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19047?source=see_link\">",
"     \"Male dyspareunia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VULVAR PAIN SYNDROMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Localized vulvodynia (vestibulodynia)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized vulvodynia (vestibulodynia) refers to pain that is 'provoked' by touching the vestibule (",
"    <a class=\"graphic graphic_figure graphicRef79727 \" href=\"UTD.htm?9/38/9824\">",
"     figure 1",
"    </a>",
"    ). In its primary form, a woman has pain from her first experience with a tampon, speculum, or sexual relations. In its secondary form, the pain develops after a period of comfortable sexual relations. The diagnosis is clinical, based on characteristic history, a positive Q-tip test eliciting pain in the vestibule (",
"    <a class=\"graphic graphic_figure graphicRef72614 \" href=\"UTD.htm?24/50/25379\">",
"     figure 2",
"    </a>",
"    ), and exclusion of other pathology. Vulvar vestibulodynia is the most common cause of sexual pain in women under age 50. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/46/37609?source=see_link\">",
"     \"Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &mdash; Dyspareunia may be reduced or prevented with topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      ointment (5 percent in a neutral base) applied to the vestibule 10 minutes before intercourse and again after intercourse, if necessary. EMLA (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/25/32150?source=see_link\">",
"       lidocaine-prilocaine",
"      </a>",
"      ) cream is an alternative therapy. Physical therapy directed at the pelvic floor muscles can also be effective since these women have superficial pelvic floor muscles that are more tonic and more responsive to pressure than women without provoked vulvar pain [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/4\">",
"       4",
"      </a>",
"      ]. Additional long-term treatment protocols for vulvar pain syndromes are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16249?source=see_link\">",
"       \"Treatment of vulvodynia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Generalized vulvodynia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized vulvodynia refers to 'unprovoked' stinging, burning, irritation, rawness, or pain anywhere on the vulva. Dyspareunia may or may not be present and may involve only post-coital exacerbation of symptoms. There may be virtually no physical findings, or there may be areas of tenderness, hyperesthesia, or hypesthesia. The diagnosis is clinical, based on characteristic findings on history and physical examination and exclusion of other causes of vulvar pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8295?source=see_link\">",
"     \"Clinical manifestations and diagnosis of generalized vulvodynia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Short-term treatment is the same as that described above for localized vulvodynia; long-term treatment is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16249?source=see_link\">",
"     \"Treatment of vulvodynia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     UROGENITAL ATROPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urogenital atrophy is the most common cause of dyspareunia in perimenopausal and menopausal women. Vulvar, vaginal, and urinary tract epithelium express a relatively large number of estrogen receptors and thus, are susceptible to the decreased levels of circulating estrogens that occur with ovarian failure at natural or iatrogenic menopause [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/5\">",
"     5",
"    </a>",
"    ]. Hypoestrogenism causes changes in the vagina and a lack of adequate vaginal lubrication with sexual arousal, both of which result in dyspareunia.",
"   </p>",
"   <p>",
"    Additional clinical manifestations include vaginal dryness, burning, pruritus, discharge, and possibly vaginal bleeding. Urinary tract symptoms (eg, frequency, recurrent infection) may also occur. On physical examination, the vaginal mucosa is thin with diffuse erythema, occasional petechiae or ecchymoses, and few or no vaginal folds. The vaginal pH is &ge;5.0. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8039?source=see_link\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mild urogenital atrophy from low estrogen levels is also seen with other conditions, such as during the postpartum period and with breastfeeding, with use of certain medications (eg, low estrogen dose contraceptives, depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    , gonadotropin releasing hormone agonists,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    ), and with hypothalamic-pituitary disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &mdash; Nonhormonal treatments include moisturizers and lubricants (eg, Replens, K-Y jelly, Astroglide). Low dose local estrogen therapy is usually effective and has negligible systemic effects. When estrogen therapy is not effective, sexual pain is probably not related to urogenital atrophy and other causes should be sought [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=see_link\">",
"       \"Treatment of vaginal atrophy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INADEQUATE LUBRICATION UNRELATED TO HYPOESTROGENIC STATES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inadequate lubrication is an important cause of dyspareunia. Estrogen deficiency (described above) predominates in the older woman, but is possible in any age group. In a younger woman, inadequate lubrication is associated with inhibited arousal resulting from inadequate foreplay technique, relationship issues and interpersonal conflict, and some medications used to treat high blood pressure or depression. Other medications that can cause significant vaginal dryness unrelated to estrogen levels include antihistamines (first generation H1 blockers, not second generation) and anticholinergic agents.",
"   </p>",
"   <p>",
"    Sj&ouml;gren's syndrome is a medical disorder associated with vaginal dryness [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/7\">",
"     7",
"    </a>",
"    ], diabetes may also be associated with decreased lubrication and sexual dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &mdash; Management of the underlying disease (physical or psychiatric), avoiding causative medications when possible (",
"      <a class=\"graphic graphic_table graphicRef67305 \" href=\"UTD.htm?39/38/40555\">",
"       table 2",
"      </a>",
"      ), and use of topical moisturizers and lubricants can be helpful.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Water-based lubricants (eg, K-Y, Astroglide, saliva, glycerine, silicone) can be used with latex condoms, but oil-based lubricants (baby oil, many hand and body lotions, petroleum jelly) reduce latex condom integrity and may facilitate breakage. There are differences among brands so patients should try different brands to see which one they like best. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=see_link\">",
"     \"Treatment of vaginal atrophy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30696?source=see_link&amp;anchor=H25#H25\">",
"     \"Male condoms\", section on 'Discuss use of lubricants and medications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Increasing the amount of foreplay, delaying penetration until maximal arousal, and frequent vaginal intercourse may improve natural lubrication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=see_link\">",
"     \"Sexual dysfunction in women: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     VAGINISMUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginismus refers to involuntary contraction of the muscles of the pelvic floor surrounding the vaginal orifice, which prevents insertion of an object (penis, digit, instrument). It is due to spasm of the perineal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    levator muscles. Primary vaginismus may be related to psychological issues, while secondary vaginismus usually represents a conditioned response to pain from a physical cause or new relationship issues [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although spasm has been considered the defining diagnostic characteristic of vaginismus for decades, this definition is controversial. Evidence from electromyography (EMG) studies does not strongly support a vaginal muscle spasm mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/11\">",
"     11",
"    </a>",
"    ]. Furthermore, neither gynecologists nor pelvic floor physical therapists can reliably diagnose vaginal muscle spasm [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some experts have proposed that the diagnoses of vaginismus and dyspareunia be collapsed into a single diagnostic entity called \"genito-pelvic",
"    <span class=\"nowrap\">",
"     pain/penetration",
"    </span>",
"    disorder\" because the two entities cannot be reliably differentiated [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/11\">",
"     11",
"    </a>",
"    ]. This diagnostic category is defined according to percentage success of vaginal penetration, pain with vaginal penetration, fear of vaginal penetration or of genito-pelvic pain during vaginal penetration, pelvic floor muscle dysfunction, and medical co-morbidity. Others have proposed that vaginismus be classified as a pain disorder, rather than a sexual disorder.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &mdash; It is important to look for a physical condition, such as infection or inflammatory dermatitis, which may have triggered the pain. If a trigger is identified, both the trigger and the vaginismus require treatment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Primary and secondary vaginismus may be treated initially with myofascial release of muscle tension in muscles of the pelvic floor, thighs and abdomen, with or without biofeedback. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33127?source=see_link\">",
"     \"Pelvic floor physical therapy for management of myofascial pelvic pain syndrome in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Desensitization techniques are then applied to give the woman control over muscle",
"    <span class=\"nowrap\">",
"     tonicity/relaxation.",
"    </span>",
"    Activities include Kegel exercises, the pelvic floor drop technique (reverse Kegel), and use of dilators. Self-insertion of dilators of gradually increasing size in and out of the vagina teach the woman that control of introital musculature can be voluntary and painless. Desensitization is the goal of dilator therapy, not physical enlargement of the vaginal opening. A small amount of topical anesthetic should always be used on any object inserted intravaginally since desensitization will not occur without painless insertion.",
"   </p>",
"   <p>",
"    Other therapeutic approaches include sex therapy, progressive relaxation, sensate focus, electromyography, biofeedback [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/13\">",
"     13",
"    </a>",
"    ], use of benzodiazepines, hypnotherapy, and Botulinum toxin type A injections [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]; none have been evaluated in well-designed studies [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     URINARY TRACT DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Painful bladder syndrome/interstitial cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with painful bladder",
"    <span class=\"nowrap\">",
"     syndrome/interstitial",
"    </span>",
"    cystitis have pain, which is associated with bladder filling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emptying, and usually accompanied by urinary frequency, urgency, nocturia, and dyspareunia. In addition, there may be chronic pelvic pain that is distinct from their bladder pain, as well as other ongoing, distinct pain symptoms, such as irritable bowel syndrome, dysmenorrhea, endometriosis, vulvodynia, or fibromyalgia. Dyspareunia may occur with superficial penile insertion or deep vaginal thrusting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no consensus on the optimal treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43369?source=see_link\">",
"     \"Management of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of acute uncomplicated cystitis are dysuria, usually in combination with frequency, urgency, suprapubic pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria. Dyspareunia may also occur. Appropriate antibiotics should be prescribed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Urethral diverticulum",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with cystitis, urethral diverticula are characterized by both dyspareunia and dysuria. On physical examination, a tender midline mass may be palpated through the anterior vaginal wall. Imaging may assist with diagnosis. Treatment is surgical excision. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26873?source=see_link\">",
"     \"Urethral diverticulum in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     VULVOVAGINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvovaginitis due to Candida albicans or Trichomonas vaginalis may cause superficial genital pain during intercourse as a result of local inflammation and edema. It is important to recognize that for both infections, wet mount can be negative for these organisms in the presence of disease; culture is essential when there is an increased index of suspicion because of symptoms, physical findings, or increased numbers of white blood cells on wet mount. Antimicrobial therapy is effective and described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/1/15386?source=see_link\">",
"     \"Candida vulvovaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1881?source=see_link\">",
"     \"Trichomonas vaginalis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bacterial vaginosis and colonization with Group B streptococcus or E. coli do not cause dyspareunia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     HYPERTONICITY OF LOCAL MUSCULATURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myofascial pelvic pain syndrome, coccydynia, pelvic floor tension myalgia, piriformis syndrome, levator ani spasm syndrome, and proctalgia fugax share hypertonicity of some of the pelvic musculature as an underlying problem, and may represent various manifestations of the same disease state. Pain is caused by involuntary spasm of the pelvic floor muscles, usually with hypersensitive trigger points. The etiology includes inflammation, childbirth, pelvic surgery, endometriosis, and trauma. Spasm induced by these entities can persist after the original insult has resolved. However, an antecedent cause may not be identified.",
"   </p>",
"   <p>",
"    During intercourse, trigger points of the pelvic floor often refer pain to the vagina, vulva, perineum, rectum, and bladder, but pain can be referred to more distant areas such as the thighs, buttocks, or lower abdomen. Irritative symptoms (eg, urinary urgency, vulvovaginal burning, rectal fullness) may be more prominent than pain. The diagnosis is clinical, based on characteristic findings on history and physical examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/28/40389?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myofascial pelvic pain syndrome in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment is multimodal and tailored to the individual patient. The general approach is to determine the trigger and then block or reduce ongoing stimuli that lead to pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/11/5305?source=see_link\">",
"     \"Treatment of myofascial pelvic pain syndrome in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33127?source=see_link\">",
"     \"Pelvic floor physical therapy for management of myofascial pelvic pain syndrome in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     POSTPARTUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perineal pain after repair of episiotomy and obstetric lacerations persists well beyond the postpartum period in some women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. Reports suggest 7 to 10 percent of women have dyspareunia 12 months postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/10\">",
"     10",
"    </a>",
"    ]. Distortion of anatomy, persistent inflamed granulation tissue, or development of a trigger point are possible causes. Previously mild myofascial pelvic pain syndrome may be aggravated by delivery. It is essential to rule out vaginitis, dermatitis, or dermatoses, as well as localized vulvodynia.",
"   </p>",
"   <p>",
"    Treatment depends on the etiology, and may involve surgical correction of distorted anatomy, ablation of granulation tissue, referral to a physiatrist, physical therapy, or therapeutic ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3433?source=see_link\">",
"     \"Repair of episiotomy and perineal lacerations associated with childbirth\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ENDOMETRIOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep dyspareunia is a common symptom of endometriosis, particularly when it involves the uterosacral ligaments or rectovaginal septum [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. The diagnosis should be suspected in women known to have endometriosis. Surgical and hormonal therapies for endometriosis are effective in reducing dyspareunia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     UTERINE RETROVERSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although uterine retroversion is a normal positional variant, some women have pain on deep penile thrusting [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/25\">",
"     25",
"    </a>",
"    ]. The configuration of the bony pelvis in these women may not provide enough room to accommodate the uterus when it is pushed posteriorly [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/26\">",
"     26",
"    </a>",
"    ]. Endometriosis may complicate the problem. Positional change during coitus is usually helpful; laparoscopic uterine suspension is another possible treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     PELVIC ORGAN PROLAPSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic organ prolapse, while usually not a cause of pain, can produce dyspareunia when there is marked descent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE DYSPAREUNIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyspareunia may develop after gynecological surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hysterectomy &mdash; Touching the vaginal apex with penis, digit, or a Q-tip may be painful posthysterectomy, even after the area is completely healed [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/29\">",
"       29",
"      </a>",
"      ]. Potential causes include persistent or recurrent pelvic disease, prolapse of a fallopian tube or ovary,",
"      <span class=\"nowrap\">",
"       levator/obturator/piriformis",
"      </span>",
"      muscle spasm, and neuropathic pain. Local injection or topical administration of 5 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      may be helpful, as well as use of drugs for neuropathic pain (eg, tricyclic antidepressant,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"      ); however, surgery may be necessary for diagnosis and therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Surgery for repair of pelvic relaxation causes dyspareunia in as many as one-third of patients. These procedures include sacrospinous ligament",
"      <span class=\"nowrap\">",
"       suspension/sacral",
"      </span>",
"      colpopexy, slings for treatment of urinary incontinence, and posterior repair. Dyspareunia is most common in repairs that use mesh. In nonmesh repairs, dyspareunia may improve after surgery for treatment of urinary incontinence [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/31\">",
"       31",
"      </a>",
"      ]. (See topic reviews on specific procedures).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     LEIOMYOMATA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with leiomyomata do not have a higher prevalence of dyspareunia than women without these tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/32\">",
"     32",
"    </a>",
"    ]. However, a leiomyoma can be the source of dyspareunia in an individual patient, especially in the case of a large posterior myoma impacted at the time of intercourse. Excision or shrinkage by embolization can eliminate the source of the pain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=see_link\">",
"     \"Overview of treatment of uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ADNEXAL PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adnexal pathology, such as an ovarian cyst, can contribute to deep dyspareunia. Ovarian neoplasms are diagnosed by ultrasonography. Treatment is expectant or surgical. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24601?source=see_link\">",
"     \"Approach to the patient with an adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=see_link\">",
"     \"Differential diagnosis of the adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12393?source=see_link\">",
"     \"Oophorectomy and ovarian cystectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PELVIC ADHESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic adhesions from surgery, infection, or endometriosis can be responsible for significant dyspareunia. Adhesions are diagnosed and treated by laparoscopy with up to 75 percent of patients receiving long-term relief after lysis of adhesions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SEMINAL PLASMA ALLERGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seminal plasma allergy or hypersensitivity is characterized by postcoital vulvovaginal itching, burning, edema, and erythema with or without systemic signs and symptoms. Systemic reactions are experienced as dyspnea, dysphagia, rhinoconjunctival complaints, generalized urticaria, angioedema, gastrointestinal symptoms, exacerbation of existing atopic eczema or anaphylactic shock. Most affected women are younger than 40 years and have a family history of atopy. Complaints occur immediately or within one hour after contact with seminal plasma. Human seminal plasma hypersensitivity may also present as vulvar vestibulitis syndrome or burning semen syndrome.",
"   </p>",
"   <p>",
"    Seminal plasma allergy is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2392?source=see_link\">",
"     \"Allergic reactions to seminal plasma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PSYCHOGENIC DYSPAREUNIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychoanalytic theory has described dyspareunia as a hysterical or conversion symptom symbolizing an unconscious intrapsychic conflict involving phobic reaction, major anxiety conflicts, hostility, or aversion to sexuality [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/9\">",
"     9",
"    </a>",
"    ]. Learning theory considers dyspareunia the result of absent or faulty learning, which may cause a woman to enter a sexual relationship with a set of negative expectations. Others have suggested that an initial painful sexual experience or sexual abuse leads to repetitive conditioned negative responses with subsequent experiences. It is likely that most patients with dyspareunia have both physical and psychologic factors that cause and then perpetuate their symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25258?source=see_link\">",
"     \"Sexual dysfunction in women: Epidemiology, risk factors, and evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment &mdash; Treatment includes psychotherapy, sexual therapy, couple education about sexuality and communication, vaginal exercises, and vaginal self-dilatation. Drug therapy, other than estrogen treatment of urogenital atrophy, is investigational. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=see_link\">",
"       \"Sexual dysfunction in women: Management\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H5\">",
"       'Urogenital atrophy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The practice of classifying vaginismus and dyspareunia primarily as sexual dysfunctions has put the treatment focus on psychosexual and interpersonal issues which, while useful, has not led to significant therapeutic progress. Reconceptualization of vaginismus and dyspareunia as primarily pain disorders that interfere with sexuality may help focus the clinician on the central phenomenon, which is pain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23128/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For example, cognitive behavior therapy shows the woman how her thought patterns, emotions, and behaviors contribute to her pain and then teaches her how to modify these thought patterns, emotions, and behaviors to decrease muscle tension and cope with and alleviate pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     LICHEN PLANUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erosive lichen planus is the most common type of vulvar lichen planus. The desquamative, erosive, chronic dermatitis often also involves the vagina. Lesions are characterized by glassy, brightly erythematous erosions with white striae or a white border (Wickham's striae) often visible along the margins (",
"    <a class=\"graphic graphic_picture graphicRef60224 \" href=\"UTD.htm?39/37/40530\">",
"     picture 1",
"    </a>",
"    ); occasionally, a violaceous border is noted, as well. The lesions may occur on the labia minora and vestibule as isolated lesions on an otherwise normal vulva, or they may be associated with marked architectural destruction, including loss of the labia minora and narrowing of the introitus. Recurrent exacerbations, slow healing, and scarring are common. Scarring can cause significant anatomic disruption, including severe stenosis of the vaginal opening and urethral obstruction. Dyspareunia and difficulty with",
"    <span class=\"nowrap\">",
"     urination/dysuria",
"    </span>",
"    are the major symptoms of severe progressive disease.",
"   </p>",
"   <p>",
"    Initial symptoms typically occur in women 50 to 60 years of age (range 29 to 82 years) and frequently present as intense pruritus or vulvar pain, soreness, or burning. However, this clinical scenario is not specific to lichen planus, as it occurs with most vulvar disorders. Treatment (eg, an ultra-potent topical glucocorticoid) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36952?source=see_link\">",
"     \"Vulvar lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     LICHEN SCLEROSUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic lichen sclerosus is expressed as white, atrophic papules that may coalesce into plaques. The lesions most frequently affect the labia minora",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    labia majora (",
"    <a class=\"graphic graphic_picture graphicRef78574 \" href=\"UTD.htm?41/38/42597\">",
"     picture 2",
"    </a>",
"    ), although the whitening may extend over the perineum and around the anus in a keyhole fashion (",
"    <a class=\"graphic graphic_picture graphicRef62753 graphicRef59461 \" href=\"UTD.htm?20/29/20952\">",
"     picture 3A-B",
"    </a>",
"    ). Dyspareunia is often a late symptom of lichen sclerosus. Pain is caused by introital stenosis, fissures, or posterior deflection of fused labial tissues at the time of intromission. Fusion over the clitoris can also cause diminished sexual sensation or even anorgasmia, although this is not common. Marked dyspareunia may occur in perimenopausal or postmenopausal women with estrogen deficiency in addition to lichen sclerosus. Treatment (eg, an ultra-potent topical glucocorticoid) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6874?source=see_link\">",
"     \"Vulvar lichen sclerosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/36/19009?source=see_link\">",
"       \"Patient information: Vaginismus (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/60/43970?source=see_link\">",
"       \"Patient information: Dyspareunia (painful sex) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women with sexual pain disorders experience genital pain just before, during, or after sexual intercourse. There are many possible etiologies of pain related to sex (",
"      <a class=\"graphic graphic_table graphicRef59848 graphicRef70497 graphicRef50537 \" href=\"UTD.htm?36/27/37310\">",
"       table 1A-C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The leading cause of sexual pain in women under the age of 50 is localized vulvodynia. In women over the age of 50, urogenital atrophy is the leading cause. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Localized vulvodynia (vestibulodynia) refers to pain that is 'provoked' by touching the vestibule. Generalized vulvodynia refers to 'unprovoked' stinging, burning, irritation, rawness, or pain anywhere on the vulva. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Vulvar pain syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Urogenital atrophy results from hypoestrogenism, typically associated with menopause. Hypoestrogenism causes changes in the vagina and a lack of adequate vaginal lubrication with sexual arousal, both of which result in dyspareunia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Urogenital atrophy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of sexual pain include: inadequate lubrication unrelated to hypoestrogenism, vaginismus, urinary tract disease, vulvovaginitis, pelvic organ prolapse, and uterine leiomyomas. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Inadequate lubrication unrelated to hypoestrogenic states'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Vaginismus'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Urinary tract disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Vulvovaginitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Pelvic organ prolapse'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Leiomyomata'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/1\">",
"      Meana M, Binik YM, Khalife S, Cohen DR. Biopsychosocial profile of women with dyspareunia. Obstet Gynecol 1997; 90:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/2\">",
"      Bachmann GA, Leiblum SR, Kemmann E, et al. Sexual expression and its determinants in the post-menopausal woman. Maturitas 1984; 6:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/3\">",
"      Danielsson I, Sj&ouml;berg I, Stenlund H, Wikman M. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health 2003; 31:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/4\">",
"      Bergeron S, Brown C, Lord MJ, et al. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther 2002; 28:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/5\">",
"      Schaffer J, Fantl JA. Urogenital effects of the menopause. Baillieres Clin Obstet Gynaecol 1996; 10:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/6\">",
"      Kao A, Binik YM, Kapuscinski A, Khalife S. Dyspareunia in postmenopausal women: a critical review. Pain Res Manag 2008; 13:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/7\">",
"      Mulherin DM, Sheeran TP, Kumararatne DS, et al. Sj&ouml;gren's syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 1997; 104:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/8\">",
"      Muniyappa R, Norton M, Dunn ME, Banerji MA. Diabetes and female sexual dysfunction: moving beyond \"benign neglect\". Curr Diab Rep 2005; 5:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/9\">",
"      Meana M, Binik YM. Painful coitus: a review of female dyspareunia. J Nerv Ment Dis 1994; 182:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/10\">",
"      Steege JF, Zolnoun DA. Evaluation and treatment of dyspareunia. Obstet Gynecol 2009; 113:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/11\">",
"      Binik YM. The DSM diagnostic criteria for vaginismus. Arch Sex Behav 2010; 39:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/12\">",
"      Reissing ED, Binik YM, Khalif&eacute; S, et al. Vaginal spasm, pain, and behavior: an empirical investigation of the diagnosis of vaginismus. Arch Sex Behav 2004; 33:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/13\">",
"      Crowley T, Goldmeier D, Hiller J. Diagnosing and managing vaginismus. BMJ 2009; 338:b2284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/14\">",
"      Shafik A, El-Sibai O. Vaginismus: results of treatment with botulin toxin. J Obstet Gynaecol 2000; 20:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/15\">",
"      Ghazizadeh S, Nikzad M. Botulinum toxin in the treatment of refractory vaginismus. Obstet Gynecol 2004; 104:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/16\">",
"      Brin MF, Vapnek JM. Treatment of vaginismus with botulinum toxin injections. Lancet 1997; 349:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/17\">",
"      McGuire H, Hawton K. Interventions for vaginismus. Cochrane Database Syst Rev 2003; :CD001760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/18\">",
"      Paterson LQ, Davis SN, Khalif&eacute; S, et al. Persistent genital and pelvic pain after childbirth. J Sex Med 2009; 6:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/19\">",
"      Ejeg&aring;rd H, Ryding EL, Sjogren B. Sexuality after delivery with episiotomy: a long-term follow-up. Gynecol Obstet Invest 2008; 66:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/20\">",
"      Buhling KJ, Schmidt S, Robinson JN, et al. Rate of dyspareunia after delivery in primiparae according to mode of delivery. Eur J Obstet Gynecol Reprod Biol 2006; 124:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/21\">",
"      Glazener CM. Sexual function after childbirth: women's experiences, persistent morbidity and lack of professional recognition. Br J Obstet Gynaecol 1997; 104:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/22\">",
"      Hay-Smith EJ. Therapeutic ultrasound for postpartum perineal pain and dyspareunia. Cochrane Database Syst Rev 2000; :CD000495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/23\">",
"      Fauconnier A, Chapron C, Dubuisson JB, et al. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 2002; 78:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/24\">",
"      Ferrero S, Esposito F, Abbamonte LH, et al. Quality of sex life in women with endometriosis and deep dyspareunia. Fertil Steril 2005; 83:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/25\">",
"      Fauconnier A, Dubuisson JB, Foulot H, et al. Mobile uterine retroversion is associated with dyspareunia and dysmenorrhea in an unselected population of women. Eur J Obstet Gynecol Reprod Biol 2006; 127:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/26\">",
"      Steege JF, Ling FW. Dyspareunia. A special type of chronic pelvic pain. Obstet Gynecol Clin North Am 1993; 20:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/27\">",
"      Perry CP, Presthus J, Nieves A. Laparoscopic uterine suspension for pain relief: a multicenter study. J Reprod Med 2005; 50:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/28\">",
"      Halperin R, Padoa A, Schneider D, et al. Long-term follow-up (5-20 years) after uterine ventrosuspension for chronic pelvic pain and deep dyspareunia. Gynecol Obstet Invest 2003; 55:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/29\">",
"      Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999; 282:1934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/30\">",
"      Lamvu G, Robinson B, Zolnoun D, Steege JF. Vaginal apex resection: a treatment option for vaginal apex pain. Obstet Gynecol 2004; 104:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/31\">",
"      Brubaker L, Chiang S, Zyczynski H, et al. The impact of stress incontinence surgery on female sexual function. Am J Obstet Gynecol 2009; 200:562.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/32\">",
"      Ferrero S, Abbamonte LH, Giordano M, et al. Uterine myomas, dyspareunia, and sexual function. Fertil Steril 2006; 86:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23128/abstract/33\">",
"      Binik YM, Reissing E, Pukall C, et al. The female sexual pain disorders: genital pain or sexual dysfunction? Arch Sex Behav 2002; 31:425.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5409 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7DB0BEB7E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23128=[""].join("\n");
var outline_f22_37_23128=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VULVAR PAIN SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Localized vulvodynia (vestibulodynia)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Generalized vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      UROGENITAL ATROPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INADEQUATE LUBRICATION UNRELATED TO HYPOESTROGENIC STATES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      VAGINISMUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      URINARY TRACT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Painful bladder syndrome/interstitial cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Urethral diverticulum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      VULVOVAGINITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      HYPERTONICITY OF LOCAL MUSCULATURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      POSTPARTUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ENDOMETRIOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      UTERINE RETROVERSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      PELVIC ORGAN PROLAPSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      POSTOPERATIVE DYSPAREUNIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      LEIOMYOMATA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ADNEXAL PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PELVIC ADHESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SEMINAL PLASMA ALLERGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PSYCHOGENIC DYSPAREUNIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      LICHEN PLANUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      LICHEN SCLEROSUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5409\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5409|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/38/9824\" title=\"figure 1\">",
"      Vulvar anatomy 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/50/25379\" title=\"figure 2\">",
"      Vulvar anatomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5409|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/37/40530\" title=\"picture 1\">",
"      Erosive lichen planus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/38/42597\" title=\"picture 2\">",
"      Lichen sclerosus vulva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/42/11941\" title=\"picture 3A\">",
"      Lichen sclerosus perianal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/4/16449\" title=\"picture 3B\">",
"      Vulvar lichen sclerosis with purpura 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5409|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/46/41708\" title=\"table 1A\">",
"      Dyspareunia differential dx1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/27/39356\" title=\"table 1B\">",
"      Dyspareunia differential dx2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/39/2685\" title=\"table 1C\">",
"      Dyspareunia differential dx3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/38/40555\" title=\"table 2\">",
"      Drugs causing dyspareunia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/21/2392?source=related_link\">",
"      Allergic reactions to seminal plasma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24601?source=related_link\">",
"      Approach to the patient with an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43032?source=related_link\">",
"      Approach to the woman with sexual pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/1/15386?source=related_link\">",
"      Candida vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8295?source=related_link\">",
"      Clinical manifestations and diagnosis of generalized vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/46/37609?source=related_link\">",
"      Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/28/40389?source=related_link\">",
"      Clinical manifestations and diagnosis of myofascial pelvic pain syndrome in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/54/8039?source=related_link\">",
"      Clinical manifestations and diagnosis of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=related_link\">",
"      Differential diagnosis of the adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30696?source=related_link\">",
"      Male condoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/38/19047?source=related_link\">",
"      Male dyspareunia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43369?source=related_link\">",
"      Management of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12393?source=related_link\">",
"      Oophorectomy and ovarian cystectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=related_link\">",
"      Overview of treatment of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/60/43970?source=related_link\">",
"      Patient information: Dyspareunia (painful sex) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/36/19009?source=related_link\">",
"      Patient information: Vaginismus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33127?source=related_link\">",
"      Pelvic floor physical therapy for management of myofascial pelvic pain syndrome in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3433?source=related_link\">",
"      Repair of episiotomy and perineal lacerations associated with childbirth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25258?source=related_link\">",
"      Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/10/34985?source=related_link\">",
"      Sexual dysfunction in women: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/11/5305?source=related_link\">",
"      Treatment of myofascial pelvic pain syndrome in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/50/6954?source=related_link\">",
"      Treatment of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16249?source=related_link\">",
"      Treatment of vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/53/1881?source=related_link\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26873?source=related_link\">",
"      Urethral diverticulum in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36952?source=related_link\">",
"      Vulvar lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/45/6874?source=related_link\">",
"      Vulvar lichen sclerosus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_37_23129="Clinical features and diagnosis of acute bacterial meningitis in adults";
var content_f22_37_23129=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of acute bacterial meningitis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23129/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23129/contributors\">",
"     Allan R Tunkel, MD, PhD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23129/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23129/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/37/23129/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/37/23129/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/37/23129/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningitis is an inflammatory disease of the leptomeninges, the tissues surrounding the brain and spinal cord, and is defined by an abnormal number of white blood cells in the cerebrospinal fluid (CSF). The meninges consist of three parts: the pia, arachnoid, and dura maters. Bacterial meningitis reflects infection of the arachnoid mater and the CSF in both the subarachnoid space and the cerebral ventricles.",
"   </p>",
"   <p>",
"    Approximately 1.2 million cases of bacterial meningitis occur annually worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/1\">",
"     1",
"    </a>",
"    ]. Meningitis is among the ten most common infectious causes of death and is responsible for approximately 135,000 deaths throughout the world each year. Neurologic sequelae are common among survivors.",
"   </p>",
"   <p>",
"    The clinical and laboratory features of acute bacterial meningitis in adults will be reviewed here. The pathogenesis, epidemiology, treatment, prognosis, and prevention of acute bacterial meningitis in adults, and issues related to acute bacterial meningitis in children and to chronic and recurrent meningitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=see_link\">",
"     \"Pathogenesis and pathophysiology of bacterial meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/38/31335?source=see_link\">",
"     \"Epidemiology of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4424?source=see_link\">",
"     \"Approach to the patient with chronic meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/26/43433?source=see_link&amp;anchor=H26#H26\">",
"     \"Approach to the adult with recurrent infections\", section on 'Meningitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of and risk factors for bacterial meningitis are discussed in detail elsewhere, but the major epidemiologic issues in adults can be summarized as follows (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/38/31335?source=see_link\">",
"     \"Epidemiology of bacterial meningitis in adults\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial meningitis can be community-acquired or healthcare-associated.",
"     </li>",
"     <li>",
"      The major causes of community-acquired bacterial meningitis in adults in developed countries are Streptococcus pneumoniae, Neisseria meningitidis, and, primarily in patients over age 50 to 60 years or those who have deficiencies in cell-mediated immunity, Listeria monocytogenes (",
"      <a class=\"graphic graphic_table graphicRef73706 \" href=\"UTD.htm?19/0/19468\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The major causes of healthcare-associated bacterial meningitis are different (usually staphylococci and aerobic gram-negative bacilli) and, in cases occurring after neurosurgery, may vary with whether or not antimicrobial prophylaxis has been given to prevent surgical site infection. Healthcare-associated bacterial meningitis may also occur in patients with internal or external ventricular drains, or following trauma (ie, cranial trauma or after basilar skull fracture with or without clinical evidence of leak of CSF).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with bacterial meningitis are usually quite ill and often present soon after symptom onset. In a series of 301 adults, for example, the median duration of symptoms before admission was only 24 hours (range one hour to 14 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Presenting manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic triad of acute bacterial meningitis consists of fever, nuchal rigidity, and a change in mental status, although an appreciable number of patients do not have all three features [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Most patients have high fevers, often greater than 38&ordm;C [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/5\">",
"     5",
"    </a>",
"    ], but a small percentage have hypothermia. Almost no patients have a normal temperature [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Headache is also common. The headache is typically described as severe and generalized. It is not easily confused with a normal headache.",
"   </p>",
"   <p>",
"    The following findings at presentation and during hospitalization were noted in a review of 279 episodes of community-acquired meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3\">",
"     3",
"    </a>",
"    ]. The frequency of headache was not noted.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fever was present in 95 percent at presentation and developed in another four percent within the first 24 hours. Among survivors in whom such data were available, 19 percent had fever for ten or more consecutive days, but most had other possible causes of continued fever. Patients with no identifiable source of fever other than meningitis had an average of four consecutive days of fever (range 0 to 14 days).",
"     </li>",
"     <li>",
"      Nuchal rigidity was present in 88 percent on initial examination, and persisted for more than seven days in some patients despite overall improvement.",
"     </li>",
"     <li>",
"      Mental status was altered in 78 percent. Most were confused or lethargic, but 22 percent were responsive only to pain and six percent were unresponsive to all stimuli.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar findings were noted in three other large series of adults with acute bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ]. At presentation, fever was present in 77 to 85 percent, neck stiffness in 83 to 94 percent, headache in 79 to 94 percent, and altered mental status in 83 percent, including coma in 14 to 16 percent.",
"   </p>",
"   <p>",
"    One or more of the classic findings on history (fever, neck stiffness, altered mental status) or physical examination (nuchal rigidity) are absent in many patients with bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2,3,5,7\">",
"     2,3,5,7",
"    </a>",
"    ]. In a 2004 review of 696 cases of community-acquired bacterial meningitis, only 44 percent had the clinical triad of fever, neck stiffness, and altered mental status [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/4\">",
"     4",
"    </a>",
"    ], although almost all patients (95 percent) presented with at least two of four symptoms (ie, headache, fever, stiff neck, and altered mental status). The classic triad was much more likely to occur in patients with pneumococcal compared to meningococcal meningitis (58 versus 27 percent). It must be noted that older adults (especially those with underlying conditions such as diabetes mellitus or cardiopulmonary disease) may present insidiously with lethargy or obtundation, no fever, and variable signs of meningeal inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, virtually all patients have at least one of the findings of the classic triad of fever, neck stiffness, and altered mental status (sensitivity 99 to 100 percent for the presence of at least one finding in a 1999 critical appraisal of ten studies of 845 episodes of meningitis) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/9\">",
"     9",
"    </a>",
"    ]. Similarly, 99 percent had at least one classic feature in the 2004 series of 696 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, the absence of all of these findings essentially excludes the presence of bacterial meningitis.",
"   </p>",
"   <p>",
"    In addition to the classic findings, a number of other manifestations, both neurologic and non-neurologic, can occur in patients with bacterial meningitis, and some findings may be suggestive of a particular bacterial etiology:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neurologic complications such as seizures, focal neurologic deficits (including cranial nerve palsies), and papilledema may be present early or occur later in the course [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3-5,9\">",
"       3-5,9",
"      </a>",
"      ]. Seizures have been described in 15 to 30 percent of patients and focal neurologic deficits in 10 to 35 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2-4,9,10\">",
"       2-4,9,10",
"      </a>",
"      ]. Hearing loss is a late complication. Papilledema is observed in &lt;5 percent of patients at the time of initial presentation.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"       Dexamethasone",
"      </a>",
"      therapy may reduce the rate of neurologic sequelae, particularly in selected patients with pneumococcal meningitis of intermediate severity [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23080?source=see_link\">",
"       \"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with Listeria meningitis have an increased tendency to have seizures and focal neurologic deficits early in the course of infection, and some patients may present with a syndrome of rhombencephalitis (manifested as ataxia, cranial nerve palsies,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nystagmus). In a review of 367 episodes of CNS infections caused by L. monocytogenes [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/11\">",
"       11",
"      </a>",
"      ], the most common findings were fever (92 percent of patients) and altered sensorium (65 percent of patients). In a prospective study of 30 adults with Listeria meningitis, 43 percent of patients had the triad of fever, neck stiffness, and altered mental status; only 37 percent of patients had focal neurologic deficits [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/12\">",
"       12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1736?source=see_link\">",
"       \"Clinical manifestations and diagnosis of Listeria monocytogenes infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Certain bacteria, particularly N. meningitidis, can cause characteristic skin manifestations, such as petechiae and palpable purpura. In two large series of patients with community-acquired bacterial meningitis, rash was present in 11 and 26 percent; among those with rash, 75 and 92 percent were associated with meningococcal meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. In another study of 258 adults with meningococcal meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/13\">",
"       13",
"      </a>",
"      ], rash was present in 64 percent and characterized as petechial in 91 percent of patients. A petechial rash is not specific for meningococcal infection, and some patients with meningococcal meningitis have a maculopapular rash [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=see_link\">",
"       \"Clinical manifestations of meningococcal infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arthritis occurs in some patients with bacterial meningitis. In a case series of 696 episodes of community-acquired bacterial meningitis, arthritis was diagnosed in 48 (seven percent) of the episodes, with N. meningitidis the etiologic agent in two-thirds of these joint infections [",
"      <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/14\">",
"       14",
"      </a>",
"      ]. Joint fluid aspiration was performed in 23 patients and was positive by culture in six (26 percent). Recognition of the concurrent arthritis is important since prolonged antibiotic therapy is necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=see_link\">",
"       \"Septic arthritis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bacterial meningitis tends to spare other organs unless severe sepsis ensues. However, if meningitis is the sequela of an infection elsewhere in the body, there may be features of that infection still present at the time of diagnosis of meningitis (eg, otitis or sinusitis).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Examination for nuchal rigidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although patients may not complain specifically of a stiff neck, it is easy to demonstrate nuchal rigidity. Passive or active flexion of the neck will usually result in an inability to touch the chin to the chest. Difficulty in lateral motion of the neck is a less reliable finding.",
"   </p>",
"   <p>",
"    Tests to illustrate nuchal rigidity (such as Kernig's and Brudzinski's signs) were originally developed and tested in patients with severe, late stage meningitis (such as that caused by tuberculosis) (",
"    <a class=\"graphic graphic_table graphicRef82677 \" href=\"UTD.htm?11/43/11963\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The classic Brudzinski's sign refers to spontaneous flexion of the hips during attempted passive flexion of the neck.",
"     </li>",
"     <li>",
"      The Kernig's sign refers to the inability or reluctance to allow full extension of the knee when the hip is flexed 90&ordm;. Kernig's test is usually performed in the supine position, but it can be tested in the seated patient.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although nuchal rigidity and Kernig's and Brudzinski's signs were described over a century ago, their accuracy was not assessed in a large, well-designed prospective study until a 2002 report of 297 patients with suspected meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/7\">",
"     7",
"    </a>",
"    ]. Suspected meningitis was defined as the presence of clinical symptoms (eg, fever, headache, stiff neck, photophobia, nausea,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vomiting) that led to performance of an LP to exclude meningeal inflammation.",
"   </p>",
"   <p>",
"    When meningitis was defined as &ge;6 white",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    of CSF, the sensitivity was extremely low (5 percent for each sign and 30 percent for nuchal rigidity); the specificity was 95 percent for each sign and 68 percent for nuchal rigidity. Neither Kernig's nor Brudzinski's sign performed much better among the 29 patients with moderate or the four patients with severe meningeal inflammation, defined as &ge;100 and &ge;1000 white",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    respectively. Nuchal rigidity was present in all four patients with severe meningeal irritation but had a specificity of only 70 percent.",
"   </p>",
"   <p>",
"    Jolt accentuation of headache may be a more sensitive maneuver for the diagnosis of meningitis. A positive test consists of accentuation of headache by horizontal rotation of the head at a frequency of two to three times per second. The diagnostic value of this maneuver has been evaluated in only a single study of 34 patients presenting to an outpatient clinic or emergency department with headache and fever [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/15\">",
"     15",
"    </a>",
"    ]. Jolt accentuation of headache had a sensitivity of 97 percent and a specificity of 60 percent for the diagnosis of CSF pleocytosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determinants of the pace of bacterial meningitis are related to both host and microbial virulence factors. Any form of bacterial meningitis that is untreated or treated very late in its course is almost uniformly fatal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Assessment of risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacterial meningitis is associated with appreciable mortality and risk of late sequelae in survivors. These issues are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H31#H31\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Mortality'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18280?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Baseline features can be used to estimate the individual patient's risk for an adverse outcome. A prognostic model was derived from a cohort of 176 adults and then validated in another cohort of 93 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/5\">",
"     5",
"    </a>",
"    ]. The in-hospital mortality was 27 percent and 9 percent had a neurologic deficit at discharge. Three baseline clinical features &mdash; hypotension, altered mental status, and seizures &mdash; were independently associated with an adverse outcome (defined as in-hospital death or neurologic deficit at discharge) and stratified the patients into three risk groups:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low risk (no clinical risk factors) &mdash; 9 percent adverse outcome",
"     </li>",
"     <li>",
"      Intermediate risk (one clinical risk factor) &mdash; 33 percent adverse outcome",
"     </li>",
"     <li>",
"      High risk (two or three risk factors) &mdash; 56 percent adverse outcome",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LABORATORY FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine blood work is often unrevealing. The white blood cell count is usually elevated, with a shift toward immature forms; however, severe infection can be associated with leukopenia. The platelet count may also be reduced. Leukopenia and thrombocytopenia have correlated with a poor outcome in patients with bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Coagulation studies may be consistent with disseminated intravascular coagulation. Results of serum chemistry tests are usually commensurate with the severity of the overall process and may reveal an anion gap metabolic acidosis or hyponatremia; in one series, hyponatremia was present in 30 percent of patients, but was usually mild and did not require specific treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood cultures are often positive and can be useful in the event that CSF cannot be obtained before the administration of antimicrobials. Approximately 50 to 90 percent of patients with bacterial meningitis have positive blood cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2,4,5\">",
"     2,4,5",
"    </a>",
"    ]; lower yields have been reported in some studies in patients with meningococcal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/19\">",
"     19",
"    </a>",
"    ]. Cultures obtained after antimicrobial therapy are much less likely to be positive, particularly for meningococcus [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Two sets of blood cultures should be obtained from all patients prior to the initiation of antimicrobial therapy.",
"   </p>",
"   <p>",
"    Tests of serum and urine for bacterial antigens, as well as cultures of mucosal surfaces for the causative pathogen, are not generally helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LUMBAR PUNCTURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Indications for CT scan before LP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Every patient with suspected meningitis should have CSF obtained unless lumbar puncture (LP) is contraindicated. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Relative contraindications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    It is not uncommon for LP to be delayed while a computed tomographic (CT) scan is performed to exclude a mass lesion or increased intracranial pressure, which rarely leads to cerebral herniation during subsequent CSF removal. However, a screening CT scan is not necessary in the majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. This was illustrated in a prospective study of 301 adults with suspected meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/22\">",
"     22",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among the 235 patients (78 percent) who underwent CT scan before LP, 24 percent had an abnormal finding but only 5 percent (11 patients) had a mass effect.",
"     </li>",
"     <li>",
"      The risk of having an abnormal CT scan was predicted by a suspicious history (eg, presence of impaired cellular immunity, history of previous central nervous system disease, or a seizure within the previous week) as well as certain findings on neurologic examination (eg, reduced level of consciousness, and focal motor or cranial abnormalities).",
"     </li>",
"     <li>",
"      Among 96 patients with none of these abnormalities, only three had an abnormal CT scan; one of these three patients had a mild mass effect but all three underwent LP without evidence of brain herniation.",
"     </li>",
"     <li>",
"      Compared to patients who did not undergo CT scan before LP, those who underwent CT scan before LP had an average of a two-hour delay in diagnosis and a one-hour delay in therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Similar risk factors for finding a mass lesion on CT were noted in another report: overall clinical impression, papilledema, focal neurologic examination, and altered mentation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/23\">",
"     23",
"    </a>",
"    ]. In this report, only 3 percent of patients had a finding on CT that was a relative contraindication for LP.",
"   </p>",
"   <p>",
"    Based upon these observations and in agreement with the 2004 Infectious Diseases Society of America (IDSA) guidelines for the management of bacterial meningitis, a CT scan of the head before LP should be performed in adult patients with suspected bacterial meningitis who have one or more of the following risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Immunocompromised state (eg, HIV infection, immunosuppressive therapy, solid organ or hematopoietic stem cell transplantation)",
"     </li>",
"     <li>",
"      History of CNS disease (mass lesion, stroke, or focal infection)",
"     </li>",
"     <li>",
"      New onset seizure (within one week of presentation)",
"     </li>",
"     <li>",
"      Papilledema",
"     </li>",
"     <li>",
"      Abnormal level of consciousness",
"     </li>",
"     <li>",
"      Focal neurologic deficit",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with these clinical risk factors should have a CT scan to identify a possible mass lesion and other causes of increased intracranial pressure.",
"   </p>",
"   <p>",
"    However, it has been suggested that a normal CT scan does not always mean that performance of an LP is safe and that certain clinical signs of impending herniation (ie, deteriorating level of consciousness, particularly a Glasgow coma scale &lt;11; brainstem signs including pupillary changes, posturing, or irregular respirations; or a very recent seizure) may be predictive of patients in whom an LP should be delayed (",
"    <a class=\"graphic graphic_table graphicRef81854 \" href=\"UTD.htm?28/62/29676\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link&amp;anchor=H13#H13\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\", section on 'Cerebral herniation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     If LP is delayed",
"    </span>",
"    &nbsp;&mdash;&nbsp;If LP is delayed or deferred, blood cultures should be obtained and antibiotics should be administered empirically before the imaging study, followed as soon as possible by the LP. In addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"     dexamethasone",
"    </a>",
"    (0.15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every six hours) should be given shortly before or at the same time as the antibiotics if the preponderance of clinical and laboratory evidence suggests bacterial meningitis with a plan to stop therapy, if indicated, when the evaluation is complete. Adjunctive dexamethasone should not be given to patients who have already received antimicrobial therapy because it is unlikely to improve patient outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23080?source=see_link\">",
"     \"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link&amp;anchor=H6#H6\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\", section on 'Avoidance of delay'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior administration of antimicrobials tends to have minimal effects on the chemistry and cytology findings [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/20,26\">",
"     20,26",
"    </a>",
"    ], but can reduce the yield of Gram stain and culture [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. However, a pathogen can still be cultured from the CSF in most patients up to several hours after the administration of antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/20,21\">",
"     20,21",
"    </a>",
"    ], with the possible exception of the meningococcus. This issue was addressed in a review of 128 children with bacterial meningitis in whom LP was first performed after initiation of therapy and serial LPs were obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/21\">",
"     21",
"    </a>",
"    ]. Among patients with meningococcal infection, CSF culture was negative in three of nine samples obtained within one hour. In contrast, 4 to 10 hours were required before CSF cultures were sterile in patients with pneumococcal meningitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Relative contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are no absolute contraindications to performing an LP, caution should be used in patients with evidence of raised intracranial pressure (eg, mass effect on CNS imaging or clinical signs of impending herniation), thrombocytopenia or another bleeding diathesis, or spinal epidural abscess. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Opening pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The opening pressure is typically elevated in patients with bacterial meningitis. In the series of 301 adults cited above, the mean opening pressure was approximately 350 mm H2O (normal up to 200 mm H2O) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2\">",
"     2",
"    </a>",
"    ]. However, there is a wide range of values as illustrated in a report of 296 episodes of community-acquired bacterial meningitis: 39 percent had values &ge;300 mm H2O, while 9 percent had values below 140 mm H2O [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     CSF analysis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;When clinical findings strongly suggest meningitis, CSF analysis including Gram stain and culture can help differentiate between bacterial and viral infection. Normal CSF values are less than 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    of protein, a CSF-to-serum glucose ratio greater than 0.6, less than 5 white blood",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    and a lactate concentration less than 3.5",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"   </p>",
"   <p>",
"    There",
"    are some CSF findings that, in the appropriate clinical setting (eg, unexplained fever and headache), are highly suggestive of bacterial meningitis. The usual CSF findings in patients with bacterial meningitis are a white blood cell count of 1000 to",
"    <span class=\"nowrap\">",
"     5000/microL",
"    </span>",
"    (range of &lt;100 to &gt;10,000) with a percentage of neutrophils usually greater than 80 percent, protein of 100 to 500",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and glucose &lt;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (with a CSF:serum glucose ratio of &le;0.4).",
"   </p>",
"   <p>",
"    An observational study found that bacterial meningitis was highly probable (&ge;99 percent certainty) when any one of the following parameters was present: a CSF glucose concentration below 34",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.9",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    a protein concentration above 220",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    a white blood cell count above",
"    <span class=\"nowrap\">",
"     2000/microL,",
"    </span>",
"    or a neutrophil count more than",
"    <span class=\"nowrap\">",
"     1180/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/27\">",
"     27",
"    </a>",
"    ]. However, clinicians must recognize that many exceptions exist, and that empiric antibiotic therapy is warranted when bacterial meningitis is suspected clinically even if the CSF abnormalities are not diagnostic.",
"   </p>",
"   <p>",
"    Determination of the CSF lactate concentration has been suggested as a useful test to differentiate bacterial from viral meningitis. Two meta-analyses that included 25 studies (1692 patients) and 31 studies (1885 patients) concluded that the diagnostic accuracy of CSF lactate was superior to that of CSF white blood cell count, glucose, and protein concentration in differentiating bacterial from aseptic meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/28,29\">",
"     28,29",
"    </a>",
"    ], although sensitivity was lower in patients who received antibiotic treatment prior to lumbar puncture [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/29\">",
"     29",
"    </a>",
"    ], and CSF lactate may be elevated in patients with other CNS diseases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Pleocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to note that a false-positive elevation of the CSF white blood cell count can be found after traumatic lumbar puncture, or in patients with intracerebral or subarachnoid hemorrhage in which both red blood cells and white blood cells are introduced into the subarachnoid space. In these instances, the following formula can be used as a correction factor for the true white blood cell (WBC) count in the presence of CSF red blood cells (RBC):",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; WBC in blood x RBC in CSF",
"    <br/>",
"    True WBC in CSF = Actual WBC in CSF - -----------------------------------------",
"    <br/>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RBC in blood",
"   </p>",
"   <p>",
"    Generalized seizures may also induce a transient CSF pleocytosis (primarily neutrophilic), although the CSF WBC count should not exceed",
"    <span class=\"nowrap\">",
"     80/microL",
"    </span>",
"    in this setting. However, CSF pleocytosis should not be ascribed to seizure activity alone unless the fluid is clear and colorless, the opening pressure and CSF glucose are normal, the CSF Gram stain is negative, and the patient has no clinical evidence of bacterial meningitis.",
"   </p>",
"   <p>",
"    Despite these typical CSF findings, the spectrum of CSF values in bacterial meningitis is so wide that the absence of one of more of the typical findings is of little value (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2-5,30\">",
"     2-5,30",
"    </a>",
"    ]. For example, in a review of 296 episodes of community-acquired bacterial meningitis, 50 percent had a CSF glucose above 40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    44 percent had a CSF protein below 200",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and 13 percent had a CSF white blood cell count below",
"    <span class=\"nowrap\">",
"     100/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3\">",
"     3",
"    </a>",
"    ]. In another series of 696 episodes of community-acquired bacterial meningitis, 12 percent had none of the characteristic CSF findings of bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Why some patients have milder CSF abnormalities cannot usually be identified. Potential causes include early presentation, recent prior antibiotic therapy, and neutropenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Gram stain",
"    </span>",
"    &nbsp;&mdash;&nbsp;A Gram stain should be obtained whenever there is suspicion of bacterial meningitis. It has the advantage of suggesting the bacterial etiology one day or more before culture results are available [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/19\">",
"     19",
"    </a>",
"    ]. The following findings may be seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28081?source=see_link\">",
"     \"Clinical microbiology review: Meningeal infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gram-positive diplococci suggest pneumococcal infection (",
"      <a class=\"graphic graphic_picture graphicRef66918 \" href=\"UTD.htm?30/48/31502\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Gram-negative diplococci suggest meningococcal infection (",
"      <a class=\"graphic graphic_picture graphicRef61788 \" href=\"UTD.htm?17/4/17486\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Small pleomorphic gram-negative coccobacilli suggest Haemophilus influenzae infection (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef81383 \" href=\"UTD.htm?41/24/42382\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Gram-positive rods and coccobacilli suggest listerial infection (",
"      <a class=\"graphic graphic_picture graphicRef59105 graphicRef70892 graphicRef54066 \" href=\"UTD.htm?23/21/23893\">",
"       picture 3A-C",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The reported sensitivity of Gram stain for bacterial meningitis has varied from 60 to 90 percent; however, the specificity approaches 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/4,30\">",
"     4,30",
"    </a>",
"    ]. In the report of 696 patients with community-acquired bacterial meningitis, CSF Gram stain had a sensitivity of 80 percent and specificity of 97 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/4\">",
"     4",
"    </a>",
"    ]. In the trial of 301 adults with bacterial meningitis, for example, the Gram stain was positive in 74 percent and the CSF culture was positive in 78 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/2\">",
"     2",
"    </a>",
"    ]. Comparable values (64 percent positive Gram stain, 77 percent positive culture) were noted in another report [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Gram stain is positive in 10 to 15 percent of patients who have bacterial meningitis but negative CSF cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/3\">",
"     3",
"    </a>",
"    ]. As noted above, the yield of both Gram stain and culture may be reduced by prior antibiotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report evaluated the clinical findings and course of 168 patients with suspected acute meningitis and a CSF white cell count above",
"    <span class=\"nowrap\">",
"     5/microL",
"    </span>",
"    who had a negative Gram stain [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/31\">",
"     31",
"    </a>",
"    ]. Approximately 20 percent had a comorbid disease, 15 percent were immunocompromised, and 52 percent received empiric antibiotic therapy. A cause for the meningitis was established in 23 percent, with most being treatable (eg, syphilis, bacteremia, and Lyme disease).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Rapid tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several rapid diagnostic tests have been developed to aid in the diagnosis of bacterial meningitis. Latex agglutination tests detect the antigens of the common meningeal pathogens in the CSF, although these tests are no longer routinely recommended because results do not appear to modify the decision to administer antimicrobial therapy and false-positive results have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/24\">",
"     24",
"    </a>",
"    ]. An immunochromatographic test for detection of S. pneumoniae in CSF was found to be 100 percent sensitive and specific for the diagnosis of pyogenic pneumococcal meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/32\">",
"     32",
"    </a>",
"    ]; the overall sensitivity is 95 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/33\">",
"     33",
"    </a>",
"    ]. More studies are needed, however, before this test can be routinely recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nucleic acid amplification tests, such as the polymerase chain reaction (PCR), have been evaluated in patients with bacterial meningitis. One study evaluated a multiplex PCR assay for detection of N. meningitidis, S. pneumoniae, and H. influenzae type b and had an overall specificity and positive predictive value of 100 percent; the negative predictive value was &gt;99 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/34\">",
"     34",
"    </a>",
"    ]. The sensitivity and specificity of CSF PCR for the diagnosis of pneumococcal meningitis is 92 to 100 percent and 100 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/33\">",
"     33",
"    </a>",
"    ]. Problems with false-positive results have been reported with PCR, however, although further refinements in this technique may make it useful for the diagnosis of bacterial meningitis especially when results of CSF Gram stain and culture are negative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Triage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preceding discussion on the frequent absence of one or more of the expected CSF findings in bacterial meningitis means that there is substantial overlap between bacterial meningitis, which is a life-threatening illness that requires hospital admission, and aseptic (usually viral) meningitis which is a less severe disease that is often monitored in the outpatient setting without antibiotic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Triage should be an individualized decision that takes into account underlying host factors, the physical examination, the neurologic examination, and the findings on CSF analysis. Multivariable prediction rules have been devised. However, the 2004 Infectious Diseases Society of America guidelines on bacterial meningitis suggested that these prediction rules should not be used to make clinical decisions in individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of a positive Gram stain, which has almost 100 percent specificity (ie, very few false positives), studies in both adults and children have concluded that, in the setting of an elevated CSF white blood cell count, no single CSF biochemical variable can reliably exclude bacterial meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/27,30,35\">",
"     27,30,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=see_link&amp;anchor=H17#H17\">",
"     \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\", section on 'CSF in CNS infection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=see_link\">",
"     \"Aseptic meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar considerations apply to the physical examination. In the series of 696 patients with bacterial meningitis cited above, only 44 percent had the classic clinical triad of fever, neck stiffness, and, altered mental status [",
"    <a class=\"abstract\" href=\"UTD.htm?22/37/23129/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=see_link\">",
"       \"Patient information: Bacterial meningitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Epidemiology of bacterial meningitis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 1.2 million cases of bacterial meningitis occur annually worldwide. Meningitis is among the ten most common infectious causes of death and is responsible for approximately 135,000 deaths throughout the world each year. Neurologic sequelae are common among survivors. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major causes of community-acquired bacterial meningitis in adults in developed countries are Streptococcus pneumoniae, Neisseria meningitidis, and, primarily in patients over age 50 to 60 years or those who have deficiencies in cell-mediated immunity, Listeria monocytogenes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major causes of healthcare-associated bacterial meningitis are staphylococci and aerobic gram-negative bacilli. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with bacterial meningitis are usually quite ill and often present soon after symptom onset. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classic triad of acute bacterial meningitis consists of fever, nuchal rigidity, and a change in mental status, although an appreciable number of patients do not have all three features. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Presenting manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood cultures are often positive and can be useful in the event that cerebrospinal fluid (CSF) cannot be obtained before the administration of antimicrobials. Approximately 50 to 90 percent of patients with bacterial meningitis have positive blood cultures. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Blood cultures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two sets of blood cultures should be obtained from all patients prior to the initiation of antibiotics. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Blood cultures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Lumbar puncture",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Every patient with suspected meningitis should have CSF obtained unless a lumbar puncture (LP) is contraindicated. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Relative contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      It is not uncommon for LP to be delayed while a computed tomographic (CT) scan is performed to exclude a mass lesion or increased intracranial pressure, which rarely leads to cerebral herniation during subsequent CSF removal. However, a screening CT scan is not necessary in the majority of patients. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Indications for CT scan before LP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A CT scan of the head before LP should be performed in adult patients with suspected bacterial meningitis who have one or more of the following risk factors:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Immunocompromised state (eg, HIV infection, immunosuppressive therapy, solid organ or hematopoietic stem cell transplantation)",
"     </li>",
"     <li>",
"      History of central nervous system disease (mass lesion, stroke, or focal infection)",
"     </li>",
"     <li>",
"      New onset seizure (within one week of presentation)",
"     </li>",
"     <li>",
"      Papilledema",
"     </li>",
"     <li>",
"      Abnormal level of consciousness",
"     </li>",
"     <li>",
"      Focal neurologic deficit (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Indications for CT scan before LP'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If LP is delayed or deferred, blood cultures should be obtained and antibiotics should be administered empirically before the imaging study, followed as soon as possible by the LP. In addition,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      (0.15",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV every six hours) should be given shortly before or at the same time as the antibiotics if the preponderance of clinical and laboratory evidence suggests bacterial meningitis with a plan to stop therapy, if indicated, when the evaluation is complete. Adjunctive dexamethasone should not be given to patients who have already received antimicrobial therapy because it is unlikely to improve patient outcome. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'If LP is delayed'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual CSF findings in patients with bacterial meningitis are a white blood cell count of 1000 to",
"      <span class=\"nowrap\">",
"       5000/microL",
"      </span>",
"      (range of &lt;100 to &gt;10,000) with a percentage of neutrophils usually greater than 80 percent, protein of 100 to 500",
"      <span class=\"nowrap\">",
"       mg/dL,",
"      </span>",
"      and glucose &lt;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (with a CSF:serum glucose ratio of &le;0.4). Despite these typical CSF findings, the spectrum of CSF values in bacterial meningitis is so wide that the absence of one of more of the typical findings is of little value (",
"      <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A Gram stain should be obtained whenever there is suspicion of bacterial meningitis. It has the advantage of suggesting the bacterial etiology one day or more before culture results are available. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Gram stain'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/1\">",
"      Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002; 186 Suppl 2:S225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/2\">",
"      de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/3\">",
"      Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/4\">",
"      van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351:1849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/5\">",
"      Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/6\">",
"      Domingo P, Mancebo J, Blanch L, et al. Fever in adult patients with acute bacterial meningitis. J Infect Dis 1988; 158:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/7\">",
"      Thomas KE, Hasbun R, Jekel J, Quagliarello VJ. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis. Clin Infect Dis 2002; 35:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/8\">",
"      Choi C. Bacterial meningitis in aging adults. Clin Infect Dis 2001; 33:1380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/9\">",
"      Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination. Does this adult patient have acute meningitis? JAMA 1999; 282:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/10\">",
"      Zoons E, Weisfelt M, de Gans J, et al. Seizures in adults with bacterial meningitis. Neurology 2008; 70:2109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/11\">",
"      Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes. 33 years' experience at a general hospital and review of 776 episodes from the literature. Medicine (Baltimore) 1998; 77:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/12\">",
"      Brouwer MC, van de Beek D, Heckenberg SG, et al. Community-acquired Listeria monocytogenes meningitis in adults. Clin Infect Dis 2006; 43:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/13\">",
"      Heckenberg SG, de Gans J, Brouwer MC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 2008; 87:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/14\">",
"      Weisfelt M, van de Beek D, Spanjaard L, de Gans J. Arthritis in adults with community-acquired bacterial meningitis: a prospective cohort study. BMC Infect Dis 2006; 6:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/15\">",
"      Uchihara T, Tsukagoshi H. Jolt accentuation of headache: the most sensitive sign of CSF pleocytosis. Headache 1991; 31:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/16\">",
"      Kaplan SL. Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis. Infect Dis Clin North Am 1999; 13:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/17\">",
"      Kornelisse RF, Westerbeek CM, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995; 21:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/18\">",
"      Brouwer MC, van de Beek D, Heckenberg SG, et al. Hyponatraemia in adults with community-acquired bacterial meningitis. QJM 2007; 100:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/19\">",
"      Geiseler PJ, Nelson KE, Levin S, et al. Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976. Rev Infect Dis 1980; 2:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/20\">",
"      Talan DA, Hoffman JR, Yoshikawa TT, Overturf GD. Role of empiric parenteral antibiotics prior to lumbar puncture in suspected bacterial meningitis: state of the art. Rev Infect Dis 1988; 10:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/21\">",
"      Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001; 108:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/22\">",
"      Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/23\">",
"      Gopal AK, Whitehouse JD, Simel DL, Corey GR. Cranial computed tomography before lumbar puncture: a prospective clinical evaluation. Arch Intern Med 1999; 159:2681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/24\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/25\">",
"      Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med 2007; 22:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/26\">",
"      Blazer S, Berant M, Alon U. Bacterial meningitis. Effect of antibiotic treatment on cerebrospinal fluid. Am J Clin Pathol 1983; 80:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/27\">",
"      Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA 1989; 262:2700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/28\">",
"      Huy NT, Thao NT, Diep DT, et al. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care 2010; 14:R240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/29\">",
"      Sakushima K, Hayashino Y, Kawaguchi T, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect 2011; 62:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/30\">",
"      Fitch MT, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis 2007; 7:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/31\">",
"      Elmore JG, Horwitz RI, Quagliarello VJ. Acute meningitis with a negative Gram's stain: clinical and management outcomes in 171 episodes. Am J Med 1996; 100:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/32\">",
"      Saha SK, Darmstadt GL, Yamanaka N, et al. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J 2005; 24:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/33\">",
"      Werno AM, Murdoch DR. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis 2008; 46:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/34\">",
"      Tzanakaki G, Tsopanomichalou M, Kesanopoulos K, et al. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae. Clin Microbiol Infect 2005; 11:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/37/23129/abstract/35\">",
"      Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics 2000; 105:316.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1287 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-17F8E0A872-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23129=[""].join("\n");
var outline_f22_37_23129=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Presenting manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Examination for nuchal rigidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Assessment of risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LABORATORY FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LUMBAR PUNCTURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Indications for CT scan before LP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      If LP is delayed",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Relative contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Opening pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      CSF analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Overview",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Pleocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Gram stain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Rapid tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Triage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Epidemiology of bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/1287\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1287|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/24/42382\" title=\"diagnostic image 1\">",
"      Gram stain CSF 3 with answer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1287|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/48/31502\" title=\"picture 1\">",
"      Gram stain CSF 1 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/4/17486\" title=\"picture 2\">",
"      Gram stain CSF 2 with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/54/14176\" title=\"picture 3A\">",
"      Gram stain CSF 5A with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/35/10815\" title=\"picture 3B\">",
"      Gram stain CSF 5B with answer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/19/6462\" title=\"picture 3C\">",
"      Gram stain CSF 5C with answer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1287|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/0/19468\" title=\"table 1\">",
"      Causes of bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/43/11963\" title=\"table 2\">",
"      Signs of meningeal irritation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/62/29676\" title=\"table 3\">",
"      Glasgow coma scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/55/14204\" title=\"table 4\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/26/43433?source=related_link\">",
"      Approach to the adult with recurrent infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4424?source=related_link\">",
"      Approach to the patient with chronic meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=related_link\">",
"      Aseptic meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=related_link\">",
"      Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/44/1736?source=related_link\">",
"      Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/52/37704?source=related_link\">",
"      Clinical manifestations of meningococcal infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28081?source=related_link\">",
"      Clinical microbiology review: Meningeal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23080?source=related_link\">",
"      Dexamethasone to prevent neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/38/31335?source=related_link\">",
"      Epidemiology of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=related_link\">",
"      Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18280?source=related_link\">",
"      Neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=related_link\">",
"      Pathogenesis and pathophysiology of bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/1/31762?source=related_link\">",
"      Patient information: Bacterial meningitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11049?source=related_link\">",
"      Septic arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=related_link\">",
"      Treatment of bacterial meningitis caused by specific pathogens in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_37_23130="Erythema migrans";
var content_f22_37_23130=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81270%7EPEDS%2F57414%7EID%2F67424%7EPEDS%2F75337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81270%7EPEDS%2F57414%7EID%2F67424%7EPEDS%2F75337&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema migrans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 241px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema migrans with central clearing and a necrotic center.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dori F Zaleznik, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema migrans lesion with uniform erythema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 300px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema migrans lesion with uniform erythema. Note that the lesion is not a perfect circle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eugene D Shapiro, MD, FAAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vesicular erythema migrans (EM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 544px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) EM lesion in a patient with Lyme disease. The lesion has the complex \"bull's eye\" appearance with central clearing and vesicular lesions.",
"    <br>",
"     (B) Vesicles may appear near the center of an erythema migrans lesion. This patient subsequently developed facial nerve palsy and had positive serology for Lyme disease.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Panel A courtesy of Robert Basow, MD; Panel B courtesy of Eugene D Shapiro, MD, FAAP.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Multiple erythema migrans lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple erythema migrans lesions of early disseminated Lyme disease. In Panel A, the more typical primary lesion is on the abdomen, with a smaller secondary lesion on the upper thigh.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eugene D Shapiro, MD, FAAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23130=[""].join("\n");
var outline_f22_37_23130=null;
var title_f22_37_23131="Active and maintenance therapy of gastroduodenal ulcers";
var content_f22_37_23131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for PPI doses in active and maintenance therapy of gastroduodenal ulcers*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose (adult) oral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dexlansoprazole",
"       </td>",
"       <td>",
"        30 to 60 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Esomeprazole",
"       </td>",
"       <td>",
"        20 to 40 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lansoprazole",
"       </td>",
"       <td>",
"        15 to 30 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Omeprazole",
"       </td>",
"       <td>",
"        20 to 40 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pantoprazole",
"       </td>",
"       <td>",
"        20 to 40 mg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rabeprazole",
"       </td>",
"       <td>",
"        20 mg",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"2\">",
"        All administered daily before breakfast",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PPI: proton pump inhibitor.",
"     <br>",
"      * As a general rule, active duodenal ulcers should be treated for four weeks and gastric ulcers for eight weeks.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Wolfe MM, Sachs G. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000; 118:S9.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23131=[""].join("\n");
var outline_f22_37_23131=null;
var title_f22_37_23132="Causes pulmonary eosinophilia";
var content_f22_37_23132=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F76875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F76875&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of pulmonary eosinophilia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drug- and toxin-induced eosinophilic lung diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nonsteroidal antiinflammatory drugs (NSAIDs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Antimicrobials (Nitrofurantoin, minocycline, sulfonamides, ampicillin, daptomycin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        L-tryptophan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Helminthic and fungal infection-related eosinophilic lung diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Transpulmonary passage of larvae (Loffler's syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Ascaris lumbricoides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Hookworm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Strongyloides stercoralis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pulmonary parenchymal invasion - mostly helminths, eg, paragonimiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Heavy hematogenous seeding with helminths",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Trichinosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Disseminated strongyloidiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Cutaneous and visceral larva migrans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Schistosomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tropical pulmonary eosinophilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Wuchereria bancrofti",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Brugia malayi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Allergic bronchopulmonary aspergillosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute eosinophilic pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic eosinophilic pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Churg-Strauss syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Idiopathic hypereosinophilic syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Idiopathic lung diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Neoplasms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nonhelminthic infections",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23132=[""].join("\n");
var outline_f22_37_23132=null;
var title_f22_37_23133="Induction chemo stage III NSCLC";
var content_f22_37_23133=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Phase II trials of induction chemotherapy followed by surgery in stage III NSCLC",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Reference, Number of Patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Induction Regimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Radiation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Response to Induction",
"       </td>",
"       <td class=\"subtitle1\">",
"        Surgical Resection Therapy (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median Survival (months)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Long-term Survival, percent (years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skarin, 1989",
"       </td>",
"       <td>",
"        CAP",
"       </td>",
"       <td>",
"        Sequential",
"       </td>",
"       <td>",
"        53",
"       </td>",
"       <td>",
"        88",
"       </td>",
"       <td>",
"        32",
"       </td>",
"       <td>",
"        31 (5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elias, 1994",
"       </td>",
"       <td>",
"        CAP",
"       </td>",
"       <td>",
"        Post-operative",
"       </td>",
"       <td>",
"        39",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        22 (5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elias, 1997",
"       </td>",
"       <td>",
"        PFL",
"       </td>",
"       <td>",
"        Post-operative",
"       </td>",
"       <td>",
"        65",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        18 (4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strauss, 1992",
"       </td>",
"       <td>",
"        PVF",
"       </td>",
"       <td>",
"        Concurrent and post-operative",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        22 (9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sugarbaker, 1995",
"       </td>",
"       <td>",
"        PV",
"       </td>",
"       <td>",
"        Post-operative",
"       </td>",
"       <td>",
"        88",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        23 (3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Choi, 1997",
"       </td>",
"       <td>",
"        PFV",
"       </td>",
"       <td>",
"        Twice daily, concurrent/post-operative",
"       </td>",
"       <td>",
"        73",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        25",
"       </td>",
"       <td>",
"        37 (5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Martini, 1993",
"       </td>",
"       <td>",
"        MPVd",
"       </td>",
"       <td>",
"        Not routinely administered",
"       </td>",
"       <td>",
"        77",
"       </td>",
"       <td>",
"        65",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        17 (5)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Burkes, 2005",
"       </td>",
"       <td>",
"        MPVd",
"       </td>",
"       <td>",
"        Not routinely administered",
"       </td>",
"       <td>",
"        68",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        19",
"       </td>",
"       <td>",
"        22 (10)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weitberg, 2001",
"       </td>",
"       <td>",
"        PE",
"       </td>",
"       <td>",
"        Concurrent",
"       </td>",
"       <td>",
"        89",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        42 (12)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reddy, 1992",
"       </td>",
"       <td>",
"        PF&plusmn;E",
"       </td>",
"       <td>",
"        Concurrent",
"       </td>",
"       <td>",
"        Not reported",
"       </td>",
"       <td>",
"        72*",
"       </td>",
"       <td>",
"        18",
"       </td>",
"       <td>",
"        32 (3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weiden, 1991",
"       </td>",
"       <td>",
"        PF",
"       </td>",
"       <td>",
"        Concurrent",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        20 (3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Albain, 1995",
"       </td>",
"       <td>",
"        PE",
"       </td>",
"       <td>",
"        Concurrent",
"       </td>",
"       <td>",
"        59",
"       </td>",
"       <td>",
"        76/63&bull;",
"       </td>",
"       <td>",
"        13/17&bull;",
"       </td>",
"       <td>",
"        27/24 (3)&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        DeCamp, 2003",
"       </td>",
"       <td>",
"        P/Taxol",
"       </td>",
"       <td>",
"        Concurrent",
"       </td>",
"       <td>",
"        62",
"       </td>",
"       <td>",
"        79",
"       </td>",
"       <td>",
"        27",
"       </td>",
"       <td>",
"        32 (5)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CAP: cyclophosphamide, doxorubicin, cisplatin; PFL: cisplatin, 5-fluorouracil (5-FU), leucovorin; PVF: cisplatin, vinblastine, 5-FU; PV: cisplatin,vinblastine; PFV: cisplatin, vinblastine, 5-FU; MPVd: mitomycin, cisplatin, vindesine; PE: cisplatin, etoposide; PF&plusmn;E: cisplatin, 5-FU &plusmn; etoposide; PF: cisplatin, 5-FU. P/Taxol: cisplatin plus pacitaxel.",
"     <br>",
"      * 72 percent resectability achieved among 86 patients deemed \"eligible for surgery\" at outset. Resectability was 47 percent among all 129 patients.",
"      <br>",
"       &bull; Resectability rate 76 versus 63 percent for stage IIIA/IIIB disease; median survival 13 versus 17 months for stage IIIA/IIIB disease; long-term survival (3-year) 27 versus 24 percent for stage IIIA/IIIB disease.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23133=[""].join("\n");
var outline_f22_37_23133=null;
var title_f22_37_23134="Pustular psoriasis - palms";
var content_f22_37_23134=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F64550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F64550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pustular psoriasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 163px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pustular collections are present on the palms of this patient with pustular psoriasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23134=[""].join("\n");
var outline_f22_37_23134=null;
var title_f22_37_23135="Thin smear in relapsing fever";
var content_f22_37_23135=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F63059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F63059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thin smear in relapsing fever",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 234px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Wright stain reveals the spirochete of relapsing fever. The concentration of spirochetes in the blood must be 10(5) or greater to be visible in a single high power microscopic field.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Alan Barbour, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_37_23135=[""].join("\n");
var outline_f22_37_23135=null;
